US20050080399A1 - Urinary catheter and method with increased resistance to obstructions - Google Patents
Urinary catheter and method with increased resistance to obstructions Download PDFInfo
- Publication number
- US20050080399A1 US20050080399A1 US10/921,356 US92135604A US2005080399A1 US 20050080399 A1 US20050080399 A1 US 20050080399A1 US 92135604 A US92135604 A US 92135604A US 2005080399 A1 US2005080399 A1 US 2005080399A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- main body
- interior passageway
- contact element
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002485 urinary effect Effects 0.000 title claims description 173
- 238000000034 method Methods 0.000 title claims description 36
- 210000002700 urine Anatomy 0.000 claims abstract description 121
- 208000007536 Thrombosis Diseases 0.000 claims abstract description 54
- 238000009825 accumulation Methods 0.000 claims abstract description 12
- 239000011248 coating agent Substances 0.000 claims abstract description 10
- 238000000576 coating method Methods 0.000 claims abstract description 10
- 238000003780 insertion Methods 0.000 claims description 123
- 230000037431 insertion Effects 0.000 claims description 121
- 210000005070 sphincter Anatomy 0.000 claims description 65
- 210000003205 muscle Anatomy 0.000 claims description 62
- 210000001635 urinary tract Anatomy 0.000 claims description 45
- 239000012530 fluid Substances 0.000 claims description 39
- 230000004913 activation Effects 0.000 claims description 18
- 230000000717 retained effect Effects 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 claims description 3
- 238000004873 anchoring Methods 0.000 claims description 3
- 230000001186 cumulative effect Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000035508 accumulation Effects 0.000 abstract description 10
- 206010061876 Obstruction Diseases 0.000 description 60
- 210000002307 prostate Anatomy 0.000 description 30
- 210000003708 urethra Anatomy 0.000 description 27
- 238000011010 flushing procedure Methods 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 17
- 238000001356 surgical procedure Methods 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000002783 friction material Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 5
- 230000035876 healing Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 238000000015 thermotherapy Methods 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000036829 Device dislocation Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/16—Male reproductive, genital organs
- A61M2210/166—Prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
Definitions
- This invention relates to an urinary catheter and the use of an urinary catheter. More particularly, the present invention relates to a new and improved catheter that reduces the incidence of obstructions in the urine flow path through the catheter, such as those arising from blood clots, and to a new and improved catheter that facilitates removing and disintegrating blood clot obstructions should they occur.
- Prostate problems such as benign prostate hyperplasia (BPH) and malignant prostate cancer
- BPH benign prostate hyperplasia
- malignant prostate cancer are common occurrences among older men.
- the effects of these diseases are generally accompanied by swelling or enlargement of the prostate gland.
- the everyday symptoms and effects of these diseases are usually troublesome.
- One such problem relates to the ability to control and achieve normal urine discharge.
- urinary tract retention When the prostate gland enlarges to the extent that it obstructs the prostatic urethra through the prostate gland, considerable difficulties arise in discharging urine at will. Such difficulties are typically referred to as urinary tract retention.
- Urinary tract retention can be either acute or chronic.
- Surgical treatments are available for relieving urinary tract retention problems, e.g. transurethral resection of the prostate (TURP).
- a TURP procedure involves surgically resecting tissue from the prostate gland to eliminate or reduce obstruction or restriction.
- Surgical operations offer a high probability of an excellent clinical outcome, but they are associated with a high degree of morbidity.
- Alternative treatments with milder side-effects include transurethral microwave thermotherapy (TUMT), radio frequency needle ablation (TUNA), interstitial laser and hot water induced thermotherapy (WIT). All of these alternative treatments involve heating the obstructive prostatic tissue until the tissue is destroyed or damaged.
- a TURP procedure involves surgically resecting tissue from the prostate gland to eliminate or relieve the obstruction.
- TURP and the different prostate heat treating techniques cause temporary side effects, for example inflammation and swelling of the prostate.
- the side effects usually require the patient to use an indwelling urine drainage catheter for a few days up to several weeks following the procedure to permit urination while the swelling subsides and the tissue of the prostate gland heals or stabilizes.
- the tissue of the prostate gland which remains viable after a TUMT or a heat treatment is quite raw and tender, and direct contact from urine can aggravate the inflammation and increase the risk of infection.
- An indwelling catheter permits the urine to pass through the tissue where the surgical procedure was performed with minimal or no contact with the treated tissue.
- the obstruction may become so significant that normal urinary functions are not possible or are only possible with great difficulty.
- the patient is taught to insert a full-length catheter whenever urination is necessary.
- medical personnel insert the full-length catheter in the urinary tract where it remains until removal by medical personnel.
- the typical type of urinary catheter used while the prostate gland heals, or on a continual basis, is a full-length urinary catheter.
- a full-length urinary catheter extends from the exterior opening of the urinary canal through the entire length of the urinary tract into the bladder.
- a clamp or other mechanical valve at the exterior of the catheter is opened to drain the urine from the bladder and is closed to terminate urination.
- a reservoir may be attached to the end of the catheter to collect the urine discharge, in which case the mechanical valve and clamp may not be used.
- the internal urinary sphincter muscle at the bladder neck which normally controls the flow of urine from the bladder into the prostatic urethra and the remainder of the urinary canal, is no longer able to perform its natural function of constricting the urethra to stop urine flow and dilating to allow urine flow.
- TURP and heat treatment surgical procedures usually destroy the internal urinary sphincter muscle.
- the full-length urinary catheter may create limitations from a social standpoint and almost always creates quality of life issues which must be confronted. Sexual activity is impossible. An increased risk of infection also results.
- Partial-length indwelling catheters typically extend only from the bladder through the prostatic urethra, and not along the entire length of the urinary tract from the bladder to the exterior opening. The reduced length permits the external urinary sphincter muscle to control urine flow in a more natural manner, while still bypassing most of the urine flow around the swollen or raw prostate gland. No sizeable part of the catheter extends out of the exterior opening of the urinary canal.
- a partial-length indwelling catheter in the proper position is essential.
- the short length may allow the catheter to move completely into the bladder or move out of the prostatic urethra into the urinary canal. Either type of unintended movement may require serious medical intervention to correct.
- a partial-length urinary catheter typically uses an inflatable balloon or other form of anchor at its end which is innermost within the body and upstream relative to the urine flow.
- the balloon is expanded, or the anchor is enlarged, within the bladder, and the catheter is then is withdrawn until the balloon or anchor contacts the bladder neck at the entrance to the urethra.
- the balloon or anchor prevents the catheter from moving out of the bladder and into the urinary canal.
- the balloon cannot prevent the partial-length urinary catheter from moving out of the prostatic urethra and into the bladder.
- One way of preventing a partial-length urinary catheter from moving into the bladder involves attaching a downstream anchor to the partial-length of catheter with a short length of thread-like material.
- the thread-like material extends through the orifice of the external urinary sphincter muscle, and the downstream anchor is positioned downstream from the external urinary sphincter muscle.
- the catheter and the anchor tube are positioned in the prostatic urethra and the urinary canal, respectively, on opposite sides of the external urinary sphincter muscle.
- the external urinary sphincter muscle is able to constrict around the thread-like material to stop urine flow and is able to dilate to permit the flow of urine.
- the normal constricted state of the external urinary sphincter muscle adjacent to the anchor tube prevents the partial-length catheter from moving into the bladder.
- Treatment of the prostate gland with a TUMT or a heat treatment usually causes the destruction of the bladder neck and results in blood clots which enter the bladder. These clots float in the urine in the bladder and enter the catheter where they can accumulate to the extent of obstructing the flow of urine through the catheter. If the patient is unable to clear the clot accumulation by urinating, then the catheter must be medically removed and replaced. Replacement of the catheter shortly after treatment causes irritation to the treatment area, can be painful for the patient, typically prolongs of the healing time period, and creates greater medical expense if the catheter must be removed and replaced.
- the problems of possible obstructions from blood clots are equally applicable to full-length and partial-length catheters.
- Another possibility of blockage of the catheter is due to obstructions from other natural body substances in the bladder or the urine. While such risks are not as significant as those risks which arise because of blood clots after a surgical procedure, such risks are nevertheless significant for those individuals who must utilize an urinary catheter on a full-time basis, because of the continual possibility of obstruction to the urine passageway through the catheter.
- the present invention pertains to a full-length or partial-length urinary catheter which extends from the bladder through the urinary tract to the exterior opening of the urinary canal.
- the catheter resists the accumulation of blood clots and obstructions within an interior urine drainage passageway of the catheter, thereby maintaining the urine drainage capability of the passageway through the catheter.
- the catheter is beneficial in avoiding entirely or reducing the number of instances where a medical or surgical procedure is required to remove and replace the entire catheter.
- the catheter also promotes better healing of the prostate gland after surgery because of the continually open urine drainage passageway which conducts the urine away from the surgically-affected area and thereby reduces the risk of infection and irritation.
- a catheter used to drain urine from a bladder to a location adjacent to an external urinary sphincter muscle of an urinary tract The urinary tract includes an urinary canal extending from the external urinary sphincter muscle to an exterior opening of the urinary canal.
- An inlet opening is located in the distal end of the catheter and has a configuration which facilitates passing urine and blood clots from the bladder into an interior urine drainage passageway of the catheter. The configuration of the inlet opening reduces blood clot accumulation and other urine flow obstructions.
- the inlet opening may assume different beneficial alternative configurations.
- the urinary opening may be defined by the absence of a longitudinal half portion of a rounded tip and a distal end portion of the catheter adjacent to the rounded tip established by longitudinally bisecting the rounded tip.
- the longitudinal half portion is established by longitudinally bisecting the rounded tip and the distal end portion adjoining the rounded tip.
- a whistle-tip shape results from this configuration.
- the inlet opening may be defined by a plurality of separate openings, each of which is spaced from an adjacent separate opening along the distal end portion adjacent to the rounded tip. Each of the separate openings communicates with the interior urine drainage passageway in the catheter.
- the inlet opening may be defined by two radially opposite openings having a transverse dimension greater than one fourth of the circumferential distance around the main body and a cross-sectional size substantially greater than the cross-sectional size of the interior passageway of the catheter.
- a couvelaire tip results from this configuration.
- the inlet opening may be defined by a substantially direct opening through a beveled tip of the catheter.
- the direct opening substantially aligns with the interior passageway of the main body and has a cross-sectional size at least equal to the cross-sectional size of the interior passageway.
- the catheter may include a low friction coating over the distal end, within the inlet opening, and along the interior passageway, to resist the attachment and the accumulation of blood clots and other obstructions.
- the catheter may also incorporate a clearing device within the internal urine drainage passageway of the catheter.
- the clearing device includes a contact element normally located in a stowed position at a distal end of the interior passageway.
- the contact element moves within the interior passageway from the stowed position past the inlet opening and along the interior passageway to a position downstream of the inlet opening in the urine flow path through the catheter.
- the movement of the contact element into contact with blood clots or other obstructions in the inlet opening and in the interior passageway disintegrates the blood clot accumulations and obstructions and facilitates passage of the clots and obstructions through the catheter with urine flow.
- an activation device is connected to the contact element, and the activation device extends through the urinary canal to a position outside of the exterior opening of the urinary canal.
- Manipulation of the activation device at the position outside of the exterior opening of the urinary canal moves the contact element to disintegrate the blood clot accumulations and other obstructions and facilitates passage of the clots and obstructions through the interior passageway with the urine.
- FIG. 1 is a perspective view of an indwelling prostatic catheter which incorporates the present invention, shown attached to an insertion tool and used with a syringe.
- FIG. 2 is an enlarged perspective view of the indwelling prostatic catheter shown in FIG. 1 with the insertion tool removed and with a balloon of the indwelling catheter expanded.
- FIG. 3 is an enlarged longitudinal cross-section view taken substantially in a longitudinal axial plane through FIG. 2 .
- FIG. 4 is an enlarged transverse cross-section view taken substantially in the plane of line 4 - 4 of FIG. 1 .
- FIG. 5 is an enlarged partial longitudinal axial cross-section view of a separable connection of the indwelling catheter-insertion tool assembly shown in FIG. 1 , taken substantially in the plane of line 5 - 5 shown of FIG. 1 .
- FIG. 6 is a perspective view of the indwelling catheter and a portion of the insertion tool shown in FIG. 1 , shown inserted within a urethra, a urethra sphincter, a prostatic urethra and a bladder of an urinary tract of a human being, with the physiology generally illustrated in cross section.
- FIG. 7 is an illustration similar to FIG. 6 showing the balloon inflated within the bladder.
- FIG. 8 is an illustration similar to FIGS. 6 and 7 showing separation of the insertion tool from the indwelling catheter.
- FIG. 9 is an illustration similar to FIGS. 6-8 showing the position and use of the indwelling catheter.
- FIG. 10 is a partial, enlarged and broken view of the catheter-insertion tool assembly shown in FIG. 1 , illustrating an alternative embodiment of the separable connection shown in FIG. 5 , and other aspects of the invention.
- FIG. 11 is a perspective view of an indwelling catheter similar to that shown in FIG. 2 with a different distal end configuration.
- FIG. 12 is a perspective view of an indwelling catheter similar to that shown in FIG. 11 with another distal end configuration.
- FIG. 13 is a perspective view of an indwelling catheter similar to that shown in FIGS. 11 and 12 with still another distal end configuration.
- FIG. 14 is a perspective view of an indwelling catheter similar to that shown in FIGS. 11-13 with a further distal end configuration.
- FIG. 15 is a cross-section view of an indwelling catheter similar to that shown in FIG. 3 which further includes an obstruction clearing device located in a stowed position.
- FIG. 16 is a cross-section view similar to that shown in FIG. 15 , showing the clearing device moved longitudinally within an interior passageway of the catheter from the position shown in FIG. 15 to an operative position which clears obstructions.
- a partial-length indwelling catheter 20 which incorporates the present invention is shown in FIG. 1 , but the present invention is also applicable to full-length catheters (not shown).
- the indwelling catheter 20 is connected to an insertion tool 22 , to form a catheter-tool assembly 24 , which allows the catheter 20 to be inserted into an urinary tract 26 of a human being, as shown in FIG. 6 .
- the insertion tool 22 is disconnected or separated from the indwelling catheter 20 to leave the catheter 20 dwelling or remaining within a prostatic urethra 28 within a prostate gland 30 , as shown in FIG. 9 .
- the catheter 20 drains urine from a bladder 32 through the prostatic urethra 28 within the prostate gland 30 to a position slightly upstream of an external urinary sphincter muscle 34 .
- the urine drains through an orifice of the the external urinary sphincter muscle 34 and into an urinary canal 36 of the urinary tract 26 .
- the catheter 20 will typically be left in the indwelling position shown in FIG. 9 for a number of days or weeks to function as a temporary stent to protect raw tissue of the prostate gland 30 , after it has been operated on to remove portions of the prostatic urethra 28 and the surrounding tissue of the prostate gland 30 in a transurethral resection of the prostate (TURP) surgical procedure, or after these tissues have been destroyed or operated on by a microwave thermotherapy treatment (TUMT) or other thermotherapy treatment.
- TUMT microwave thermotherapy treatment
- the catheter 20 can also be used as a stent through the prostatic urethra 28 when it has been constricted to the point where urine will no longer pass effectively as a result of swelling in the prostate gland 30 due to benign prostate hyperplasia (BPH) or other obstructions or abnormalities.
- BPH benign prostate hyperplasia
- the indwelling catheter 20 is positioned as shown in FIG. 9 by pushing the catheter 20 into the urinary tract 26 with the insertion tool 22 until a distal end 38 of the indwelling catheter 20 enters the bladder 32 as shown in FIG. 6 .
- a balloon 40 on the indwelling catheter 20 is inflated with fluid conducted through an inflation passageway 42 of an inflation tube 44 ( FIG. 3 ) until the balloon 40 is larger in diameter than a neck 46 of the bladder 32 surrounding the prostatic urethra 28 .
- the inflation fluid may be gas, such as air, or liquid such as saline solution.
- the balloon 40 is preferably inflated from an inflation pump such as a syringe 48 which is connected to a valve assembly 50 at the end of the inflation tube 44 ( FIG. 1 ).
- the insertion tool 22 is pulled backward until the inflated balloon 40 is seated on the bladder neck 46 , as shown in FIG. 7 .
- the balloon 40 prevents the indwelling catheter 20 from moving out of the bladder 32 , through the external urinary sphincter muscle 34 and into the urinary canal 36 .
- the insertion tool 22 continues withdrawal movement of the insertion tool 22 causes it to separate from the catheter 20 at a separable connection 52 ( FIG. 1 ) between the indwelling catheter 20 and the insertion tool 22 as shown in FIG. 8 , thereby leaving the indwelling catheter 20 in its final, indwelling position shown in FIG. 9 .
- the insertion tool 22 is thereafter withdrawn and removed from within the urinary canal 36 .
- the inflation tube 44 remains within the urinary canal 36 .
- proximal and distal are used in this description in relation to the medical practitioner who inserts the catheter 20 into the urinary tract 26 at the exterior opening of the urinary canal 36 . Accordingly, the portions of the catheter 20 which are the most internal within the patient are referred to as “distal,” and the portions of the catheter 20 which are closest to the exterior opening of the urinary canal 36 are referred to as “proximal.” The distal portions of the catheter are therefore located more interiorly within the urinary tract 26 than are the proximal portions of the catheter. The distal portions of the catheter are upstream relative to the normal direction of urine flow, and the proximal portions of the catheter are downstream relative to the normal direction of urine flow.
- the balloon 40 is located near the distal end of the catheter 20 , and a distal end of the inflation tube 44 connects to a proximal end of a main body 58 of the catheter 20 at a location upstream or distal of the external urinary sphincter muscle 34 .
- the inflation tube 44 is formed with a permanently helically coiled section 54 shown in FIGS. 1-3 and 6 - 9 .
- the coiled section 54 is resilient both in the transverse dimension and in the longitudinal dimension.
- the inflation tube 44 has sufficient strength to maintain the coiled section 54 in the coiled configuration within the urinary canal 36 after removal of the insertion tool 22 . Because of the resiliency of the coiled section 54 , the coiled section 54 presses against the interior of the urinary canal 36 .
- the orifice through the external sphincter 34 is normally closed except during urination thus preventing the coiled section 54 from migrating distally or upstream past the external sphincter 34 .
- the coiled section 54 resists movement along the urinary canal 36 to hold the indwelling catheter 20 from moving along the urinary canal 36 .
- the coiled section 54 also minimizes discomfort to the patient or irritation to the urinary canal 36 .
- the coiled section 54 is not disruptive to the flow of urine through the urinary canal 36 because the coiled section 54 provides a fluid-flow path through an open center of the coils.
- the coiled section 54 extends around the exterior of the insertion tool 22 , as shown in FIG. 4 .
- the coiled section 54 assists in holding the inflation tube 44 adjacent to the insertion tool 22 while the indwelling catheter 20 and the insertion tool 22 are inserted in the urinary tract 26 .
- the coiled section 54 therefore assists in moving the inflation tube 44 into the urinary tract 26 along with the insertion tool 22 .
- the helically coiled section 54 is loosely wound around the insertion tool 22 , thereby allowing the insertion tool 22 to be withdrawn through the center of the coiled section 54 as the insertion tool 22 is disconnected from the indwelling catheter 20 .
- the coiled section 54 is located a short distance proximally from the proximal end of the main body of the indwelling catheter 20 .
- the length of the inflation tube 44 between the proximal end of the indwelling catheter 20 and the coiled section 54 is sufficient to locate the coiled section 54 within the urinary canal 36 at a position slightly proximal of the urinary sphincter muscle 34 , as shown in FIGS. 6-9 .
- the coiled section 54 of the inflation tube 44 functions as an anchor to assist in holding the indwelling catheter 20 in the urinary tract 26 in the position shown in FIG. 9 .
- the coiled section 54 prevents the indwelling catheter 20 from moving distally from the position shown in FIG. 9 , as a result of the coils of the coiled section 54 contacting a constriction in the urinary tract caused by constriction of the sphincter muscle 34 .
- the coiled section 54 contacts the constriction to resist the distal movement of the indwelling catheter 20 and to prevent it from moving into the bladder 32 .
- the inflated balloon 40 creates a restriction at the distal end 38 of the indwelling catheter 20 to prevent it from moving proximally along the urinary tract 26 and out of the urinary canal 36 .
- the indwelling catheter 20 resists movement either into or out of the bladder 32 and out of the prostatic urethra. Instead, the indwelling catheter 20 is maintained in the use position.
- urine or other fluid from the bladder 32 is able to flow through an interior passageway 56 ( FIG. 3 ) in the indwelling catheter 20 and out of the proximal end of the catheter 20 past the dilated urinary sphincter muscle 34 ( FIG. 9 ).
- the external urinary sphincter muscle 34 retains the capability to constrict or close around the inflation tube 44 to stop the urine flow.
- the urine is discharged into the urinary canal 36 in the normal manner.
- the final indwelling use position of the catheter 20 permits normal control by the external urinary sphincter muscle 34 over urine flow.
- the indwelling catheter 20 includes a main or central body 58 , preferably made from silicone rubber.
- the main body 58 has a generally cylindrical exterior shape.
- the main body 58 includes a sidewall 60 which defines the passageway 56 through the main body 58 .
- An end piece 62 is either attached to or integral with the main body 58 at the distal end 38 of the catheter 20 .
- the end piece 62 has a tip configuration adapted to facilitate insertion of the catheter 20 and the insertion tool 22 into the urinary tract 26 .
- At least one and preferably a pair of urine inlet openings 64 are formed through the end piece 62 .
- the openings 64 communicate between the exterior of the end piece 62 and the passageway 56 of the main body 58 . Urine from the bladder 32 flows through the openings 64 and into and through the passageway 56 to the other proximal end of the main body 58 .
- the balloon 40 is formed by a flexible sleeve 66 of relatively thin, flexible, expandable, usually-transparent and non-porous material which is attached with fluid-tight seals 68 and 70 around the exterior of the main body 36 .
- a first fluid-tight seal 68 is located slightly proximally of the distal end of the main body 58 where the end piece 62 is attached, and a second fluid-tight seal 70 is spaced proximally along the main body 58 from the first seal 68 by a distance approximately equal to the axial length of the flexible sleeve 66 .
- the fluid-tight seals 68 and 70 are preferably formed by attaching the flexible sleeve 66 to the main body 58 with an adhesive or by thermal welding.
- the flexible sleeve 66 is positioned over the top of and extends axially on opposite sides of an opening 72 from the main body 58 .
- the fluid-tight seals 68 and 70 are located distally and proximally of the opening 72 , respectively. Fluid is introduced into a volume 74 at the exterior of the main body 58 between the fluid-tight seals 68 and 70 and within the flexible sleeve 66 , causing the flexible sleeve 66 to expand outward and create the balloon 40 .
- An inflation conduit 76 communicates with the opening 72 , as shown in FIG. 3 .
- the inflation conduit 76 is formed within the sidewall 60 of the main body 58 .
- a distal end of the inflation tube 44 is inserted into a proximal end of the inflation conduit 76 , as shown in FIGS. 3 and 5 .
- the fluid is delivered from the syringe 48 ( FIG. 1 ) into the inflation passageway 42 of the inflation tube 44 and flows into the inflation conduit 76 , out of the opening 72 and into the volume 74 beneath the flexible sleeve 66 , causing the flexible sleeve 66 to expand into the form of the balloon 40 .
- Inserting the distal end of the inflation tube 44 into the inflation conduit 76 allows the inflation tube 44 to bypass or go around the separable connection 52 between the indwelling catheter 20 and the insertion tool 22 .
- a strong fluid-tight bond is formed by attaching the inflation tube 44 into the inflation conduit 76 with an adhesive. The attachment maintains the inflation tube 44 connected to the main body so that pulling on the inflation tube from the exterior of the urinary canal 36 will remove the catheter 20 from the urinary tract 26 without the inflation tube 44 breaking away from the main body 58 .
- the inflation tube 44 also serves as a tether for the catheter 20 .
- the communication between the inflation passageway 42 and the inflation conduit 76 permits the communication between the inflation passageway 42 and the inflation conduit 76 to remain intact and fluid tight after the insertion tool 22 has separated from the indwelling catheter 20 while the catheter 20 remains positioned within the urinary tract.
- the continued integrity of the inflation passageway between the balloon 40 and the valve assembly 50 allows the balloon 40 to be periodically reinflated while the indwelling catheter 20 is in use, if necessary. Periodic reinflation may be necessary as a result of minute leaks in the balloon 40 , the valve assembly 50 or the passageways connecting the balloon 40 and the valve assembly 50 .
- the inflation tube 44 has a length which extends from the main body 58 of the indwelling catheter 20 through the urinary canal 36 to the outside of the human body.
- the length of the inflation tube 44 is sufficient to position the valve assembly 50 at the exterior of the human body.
- the inflation tube 44 has sufficient rigidity to prevent the inflation passageway 42 within the tube 44 from collapsing from contact with the tissue of the urinary tract 26 , but the rigidity is not so great as to prevent a moderate amount of flexibility in the inflation tube 44 .
- the moderate flexibility of the inflation tube 44 allows it to extend through the typical curves of the urinary tract 26 .
- the valve assembly 50 is of a conventional construction and includes a receptacle 78 into which a nozzle 80 of the syringe 48 is inserted, as shown in FIG. 1 .
- the valve assembly 50 also includes a conventional internal check valve (not shown) which closes the inflation passageway 42 at the valve assembly 50 when the nozzle 80 is removed from the receptacle 78 . In this manner, fluid from within the balloon 40 is prevented from escaping through the inflation passageway 42 when the syringe 48 is disconnected from the valve assembly 50 , but the check valve permits fluid from the syringe 48 to inflate the balloon 40 when a plunger (not specifically shown) of the syringe 48 is depressed.
- the balloon 40 will remain inflated after the syringe 48 is disconnected from the valve assembly 50 .
- the syringe 48 is easily connected to the valve assembly 50 for doing so.
- the inflation passageway 42 can be sealed at a proximal end after the balloon 40 has been inflated.
- a knot may be tied or an obstruction formed (neither shown) in the proximal end of the inflation tube 44 at a location spaced proximally from the end of the penis at the external opening of the urinary canal.
- the knot or obstruction seals the inflation passageway 42 and prevents the fluid from escaping through the passageway to maintain the balloon 40 inflated.
- the inflation tube 42 is cut at a position slightly proximally of the knot or obstruction.
- the inflation tube 44 without the valve assembly 50 extends only a modest distance from the open end of the urinary canal 36 . Greater comfort and convenience is promoted because there is no sizable apparatus to deal with, such as the valve assembly 50 connected to the proximal end of the inflation tube 44 .
- the knot or obstruction can be cut from the end of the inflation tube 44 and a suitable connector attached to allow the syringe 48 to introduce additional fluid. After suitable inflation, another knot can be tied or an obstruction formed in the remaining proximal portion of the inflation tube 40 . Releasing the fluid through the inflation passageway 42 collapses the balloon 40 and allows the catheter 20 to be pulled out of the urinary canal 36 by pulling on the inflation tube 44 .
- the insertion tool 22 is a flexible tubular structure and is generally configured similar to the distal portion of a typical full-length urinary catheter.
- the insertion tool 22 is at least long enough to extend from outside of the body into the urinary canal 36 and prostatic urethra 28 to a point that will place the indwelling catheter 20 in the final desired use position.
- the insertion tool 22 is preferably made from silicone rubber, but has sufficient structural integrity to transfer pushing forces supplied from the outside of the body longitudinally along the length of the insertion tool 22 , thereby allowing the insertion tool 22 with the attached indwelling catheter 20 to be moved distally into the urinary tract 26 .
- a proximal end of the insertion tool 22 may take the form of a hollow handle 82 or enlargement, by which to grip the insertion tool 22 and apply pushing force to it during insertion in the urinary tract 26 .
- the separable connection 52 between the insertion tool 22 and the indwelling catheter 20 includes a sleeve 84 , shown in FIG. 5 .
- the sleeve 84 is rigidly connected to the distal end of the insertion tool 22 by an adhesive, for example.
- a distal portion of the sleeve 84 projects beyond the distal end of the insertion tool 22 and into the interior passageway 56 of the catheter.
- the distal portion of the sleeve 84 has an exterior diameter which frictionally fits within the interior passageway 56 , and the friction created by the insertion of the sleeve 84 into the interior passageway 56 is sufficient to retain the indwelling catheter 20 to the insertion tool 22 during manipulation of the catheter-tool assembly 24 within the urinary tract 26 during insertion and placement, prior to inflation of the balloon 40 .
- the degree of frictional resistance between the distal end of the sleeve 84 and the main body 58 at the proximal end of the interior passageway 56 is not so great as to prevent the indwelling catheter 20 from separating from the insertion tool 22 once the balloon 40 has been inflated and seated against the bladder neck 46 .
- the amount of frictional resistance between the distal portion of the sleeve 84 and the proximal end of the main body 58 at the proximal end of the interior passageway 56 can be increased by forming serrations on the exterior of the distal end of the sleeve 84 .
- the resilient material of the main body 58 will deform slightly around the serrations to further assist in holding the indwelling catheter 20 to the insertion tool 22 , but the amount of deformation is not so great as to prevent separation of the indwelling catheter 20 and the insertion tool 22 at the separable connection 52 .
- the sleeve 84 has a center opening 86 formed through it to provide a fluid flow path from the passageway 56 through the sleeve 84 .
- the catheter-tool assembly 24 is inserted and used in the manner illustrated in FIGS. 6-9 .
- the catheter 20 and the insertion tool 22 are inserted into the urinary tract 26 through the urinary canal 36 , in a manner similar to the way that a conventional full-length urinary catheter would be inserted.
- the insertion force is applied by pushing on the insertion tool 22 and on the handle 82 attached at its proximal end. Distal movement of the catheter-tool assembly 24 continues until the rounded end piece 62 and a significant distal portion of the indwelling catheter 20 are located in the bladder 32 .
- the insertion is sufficient to assure that the flexible sleeve 66 will be located within the bladder 32 .
- the coiled section 54 which is wrapped around the insertion tool 22 , helps keep the forward or distal portion of the inflation tube 44 aligned with and progressing with the indwelling catheter 20 .
- the balloon 40 is inflated as shown in FIG. 7 .
- Inflation is achieved by connecting the syringe 48 to the valve assembly 50 , and depressing the plunger (not shown) of the syringe 48 to force fluid through the inflation passageway 42 of the inflation tube 44 , into the inflation conduit 76 , through the opening 72 and into the interior volume 74 , causing the flexible sleeve 66 to expand into the balloon 40 .
- the insertion tool 22 is pulled to move the catheter-tool assembly 24 in the proximal direction until the inflated balloon 40 seats against the bladder neck 46 .
- the balloon 40 With the balloon 40 seated against the bladder neck 46 , continued proximal movement of the insertion tool 22 causes the separable connection 52 to separate the indwelling catheter 20 from the insertion tool 22 , as shown in FIG. 8 .
- the balloon 40 prevents the indwelling catheter 20 from coming out of the urinary tract 26 with the insertion tool 22 because the expanded balloon 40 is larger than the bladder neck 46 .
- the coiled section 54 of the inflation tube 44 being located proximally from the external urinary sphincter muscle 34 , prevents the indwelling catheter 20 from moving into the bladder 32 .
- the continued withdrawal of the insertion tool 22 is not inhibited by the coiled section 54 , because the body of the insertion tool 22 moves through the interior of the coiled section 54 .
- the length of the inflation tube 44 is sufficient to locate the valve assembly 50 at the exterior of the urinary tract 26 .
- the balloon 40 remains inflated in the bladder 32 , and the proximal end of the main body 58 of the indwelling catheter 20 extends through the prostatic urethra 28 but does not extend through the external urinary sphincter muscle 34 .
- the coiled section 54 is located on the opposite or proximal side of the external urinary sphincter muscle 34 . In this final position, the balloon 40 prevents the indwelling catheter 20 from moving out of the prostatic urethra 28 and into the urinary canal 36 , while the coiled section 54 prevents the indwelling catheter 20 from moving out of the prostatic urethra 28 and into the bladder 32 .
- the inflation tube 44 does not interfere with the ability of the urinary sphincter muscle 34 to constrict around the inflation tube 44 and naturally stop the urine flow. Similarly, the inflation tube 44 does not interfere with the natural ability of the external urinary sphincter muscle 34 to dilate, as shown in FIG. 9 , and thereby naturally allow urine to flow through the interior passageway 56 of the indwelling catheter 20 and into the urinary canal 36 . In this manner, the inflation tube 44 does not interfere with the natural control functions of the external urinary sphincter muscle 34 .
- the urinary sphincter muscle 34 When the urinary sphincter muscle 34 is dilated, the urine flows from the bladder 32 through the openings 64 and into the interior passageway 56 in the main body 58 , as understood from FIG. 3 .
- the flow of urine through the interior passageway 56 largely bypasses the prostatic urethra 28 or the prostate gland tissue if the prostatic urethra 28 has been removed by a surgical procedure.
- the dilated urinary sphincter muscle 34 FIG. 9
- the balloon 40 prevents the indwelling catheter 20 from exiting the bladder 32 and moving into the dilated urinary sphincter muscle 34 .
- the contact of the coiled section 54 against the urethra of the urinary canal 36 resists movement of the indwelling catheter 20 into and out of the bladder 32 .
- the inflation tube 44 can be held at the valve assembly 50 to resist distal movement of the indwelling catheter 20 during urination when the urinary sphincter muscle 34 is dilated, if necessary or desirable. In this manner, the indwelling catheter 20 stays in position even when the urinary sphincter muscle 34 is dilated.
- indwelling catheter 20 When the indwelling catheter 20 is no longer needed, typically as a result of natural healing of the prostate gland 30 after a surgical or heat treatment procedure, or if it is necessary to periodically replace the indwelling catheter 20 , removal is accomplished after deflating the balloon 40 .
- Deflation is accomplished by inserting the syringe 48 into the valve assembly 50 and moving the plunger (not shown) of the syringe 48 outward to withdraw fluid from the inflation passageway 42 .
- the insertion of the syringe 48 in the valve assembly 50 opens the check valve within the valve assembly 50 and allows the fluid to be withdrawn.
- the inflation tube 44 may be cut at a location distal of the knot or obstruction to allow the fluid to escape.
- the escaping fluid causes the balloon 40 to deflate, and the flexible sleeve 66 moves to a collapsed position (shown in FIGS. 1 and 6 ) adjacent to the main body 58 of the indwelling catheter 20 .
- the inflation tube 44 is pulled outward by gripping and pulling on the valve assembly 50 or the proximal end of the inflation tube 44 .
- Force is transferred through the inflation tube 44 to the main body 58 of the indwelling catheter 20 .
- the pulling force constricts and elongates the coils of the coiled section 54 , thereby reducing their transverse dimension as a result of longitudinally separating the individual coils with the pulling force.
- the reduced transverse dimension lessens or eliminates contact with the urinary canal 36 . In this manner the coiled section does not inhibit removal of the catheter or induce significant discomfort as it moves through the urinary canal.
- the amount of force transferred is sufficient to move the main body 58 of the indwelling catheter 20 past the urinary sphincter muscle 34 and into the urinary canal 36 .
- the deflated balloon 40 does not resist movement of the distal end of the indwelling catheter 20 through the bladder neck 46 .
- Continued pulling movement on the inflation tube 44 moves the indwelling catheter 20 through the urinary canal 36 until the indwelling catheter 20 is completely withdrawn from the proximal end of the urinary canal 36 .
- One approach which avoids replacing the catheter under circumstances where blood clots accumulate in the interior passageway 56 is to flush the interior passageway 56 with saline or other appropriate liquid on a periodic basis. To do so, it is necessary to establish fluid communication through the urinary canal 36 , the constricted external urinary sphincter muscle 34 and into the interior passageway 56 of the catheter 20 .
- the most direct manner of establishing this type of fluid communication is to maintain the insertion tool 22 connected to the indwelling catheter 20 , so that the flushing fluid can be supplied through an interior channel 88 of the insertion tool 22 from the handle 82 , as understood from FIG. 10 .
- the flushing fluid passes through the interior channel 88 and through the center opening 86 of the sleeve 84 and into the passageway 56 of the indwelling catheter 20 .
- the flushing fluid forces any blood clots which accumulated in the interior passageway 56 back into the bladder 32 ( FIG. 6 ) or dissolves the clots within the interior passageway 56 . Removing the clots relieves the obstruction and allows urine to flow through the indwelling catheter in the manner described.
- the insertion tool 22 must remain connected to the indwelling catheter 20 during this time so that the interior channel 88 of the insertion tool 22 remains in fluid communication with the interior passageway 56 , through the center opening 86 of the sleeve 84 .
- the insertion tool 22 may be left in place for approximately the first twenty-four hours.
- the natural friction between the proximal end of the main body 58 of the indwelling catheter 20 and the distal portion of the sleeve 84 connected to the insertion tool 22 may be sufficient to maintain the insertion tool 22 connected to the indwelling catheter in some circumstances.
- the patient may be released from the supervision of medical personnel immediately after the procedure and will be ambulatory during the first twenty-four hour period after the procedure. Movement of the patient under these circumstances may tend to create enough force on the insertion tool 22 to disconnect the insertion tool from the indwelling catheter prematurely before the risk of blood clots has subsided.
- a bridging structure preferably in the form of a relatively fine thread-like cord 90 , is used to maintain temporarily the separable connection 52 of the indwelling catheter 20 and the insertion tool 22 , as shown in FIG. 10 .
- the cord 90 extends from the interior passageway 56 through a small hole 92 in the sidewall 60 of the main body 58 of the indwelling catheter 20 .
- the cord 90 extends across and bridges the separable connection 52 along an outside surface of the main body 58 of the indwelling catheter and along an outside surface of a tubular main body 98 of the insertion tool 22 .
- the cord also extends through another small hole 94 in a sidewall 96 of a main tubular body 98 of the insertion tool 22 , and into the interior channel 88 .
- the two opposite free-end portions of the cord 90 extend along the length of the interior channel 88 and terminate within the hollow interior of the handle 82 .
- the terminal end portions of the cord 90 each loop through small holes 100 and 102 formed in a sidewall 104 of a main body 106 of the handle 82 .
- Knots 108 are formed in the terminal end portions of the cord 90 within the hollow interior of the handle 82 to hold each end of the cord 90 in place relative to the handle 82 .
- any slack longitudinal length of the cord 90 is eliminated when the knots 108 are tied in the terminal ends of the cord 90 . Eliminating any longitudinal slack in the cord 90 pulls together the proximal end of the indwelling catheter 20 and the distal end of the insertion tool 22 . The cord 90 therefore prevents the indwelling catheter 20 from separating from the insertion tool 22 at the separable connection 52 .
- the communication channel through the interior channel 88 , the center opening 86 of the sleeve 84 and the interior passageway 56 is maintained so long as the cord 90 connects the indwelling catheter 20 and the insertion tool 22 .
- flushing fluid may be forced from the handle 82 through the interior channel 88 , through the center opening 86 and into the interior passageway 56 .
- the flushing fluid dissolves any clots within the interior passageway 56 , and keeps the passageway 56 unobstructed for urine flow from the bladder.
- the dissolved clots may flow from the interior passageway 56 through the interior channel 88 , or the clots may be pushed back into the bladder with the flushing fluid.
- urine from the bladder will also flow through this open path.
- one or both of the knots 108 is untied or cut.
- One end of the cord 90 is pulled in the proximal direction, which moves the other free end of the cord into the interior channel 88 , through the holes 92 and 94 and then out of the interior channel 88 , thereby disconnecting the indwelling catheter 20 from the insertion tool 22 at the separable connection 50 .
- the insertion tool 22 is pulled in the proximal direction to separate it from the indwelling catheter 20 in the manner previously described and shown in FIG. 8 .
- the indwelling catheter 20 remains in the use position shown in FIG. 9 .
- the resistance to clotting, both before and after the insertion tool 22 is removed from the indwelling catheter 20 is enhanced by coating the indwelling catheter 20 and portions of the insertion tool 22 with a layer or coating 109 of low friction material, such as parylene or a hydrophilic material, as shown in FIG. 3 .
- the coating 109 of the low friction material is applied to the main body 58 , to cover its sidewall 60 on the exterior and interior, including the passageway 56 , the end piece 62 and the openings 64 within the end piece 62 .
- an outer layer 109 of the low friction material may be integrally made a part of the sidewall 60 , including the passageway 56 and the openings 64 .
- the low friction material reduces the adherence of the blood clots within the openings 64 and in the passageway 56 , and reduces the frictional force holding those blood clots in the openings 64 and the passageway 56 .
- the reduced adherence or frictional holding force makes it easier to dislodge the clots, with natural fluid pressure from the bladder or when flushing the indwelling catheter with fluid through the insertion tool in the manner previously described, or in conjunction with the action of a clearing device described below.
- the low friction material on the interior surface of the passageway 56 also reduces the resistance to the flow of urine and clots or other potential obstruction through the passageway 56 .
- the low friction material on the exterior surface of the main body 58 and on the exterior surface of the insertion tool 22 facilitates insertion of the indwelling catheter in the urinary canal 36 .
- Another technique for obtaining increased resistance to blood clot obstructions of the interior passageway 56 within the catheter 20 is to increase the size of the inlet opening or openings 64 through the end piece 62 , or to orient the inlet opening 64 in a manner which inhibits clot accumulation, or to do both.
- the cross-sectional size of the inlet opening or the cumulative cross-sectional sizes of all of the inlet openings should be substantially greater than the cross-sectional size of the interior passageway 56 , preferably at least two to four or more times greater.
- Indwelling catheters 20 a - 20 d which employ inlet openings 64 of increased size and direct orientation are shown in FIGS. 11-14 .
- the layer or coating 109 ( FIG. 3 ) of the low friction material may also be used in conjunction with the catheters 20 a - 20 d shown in FIGS. 11-14 .
- the catheter 20 a shown in FIG. 11 has a single enlarged urine drainage inlet opening 64 a formed in the end piece 62 a .
- the end piece 62 a retains the longitudinal half structure or portion of the rounded distal end 38 of the end piece 62 ( FIGS. 2 and 3 ), but the other longitudinal half portion is eliminated for a substantial longitudinal distance extending proximally from the most distal point of the rounded end 38 to create the substantially enlarged inlet opening 64 a .
- the shape of the end piece 62 a and the inlet opening 64 a cause the distal end of the indwelling catheter 20 a to assume the shape or configuration of a whistle. For that reason, the catheter 20 a is referred to as having a whistle tip 110 .
- the substantially enlarged inlet opening 64 a into the interior passageway 56 ( FIG. 3 ) from the bladder 32 makes it difficult for blood clots to accumulate within the inlet opening 64 a and to obstruct urine flow into and through the passageway 56 .
- the rounded distal end portion of the whistle tip 110 facilitates the insertion of the catheter 20 a into the urinary canal 36 .
- the indwelling catheter 20 b shown in FIG. 12 has multiple urine drainage inlet openings 64 b spaced at longitudinal and circumferential positions around the end piece 62 b .
- Each of the inlet openings 64 b communicates from the exterior of the end piece 62 b into the interior passageway 56 .
- Each of the inlet openings 64 b is approximately the same size as, or slightly smaller than, each of the pair of inlet openings 64 in the rounded distal end 38 of the end piece 62 ( FIGS. 2 and 3 ), but the multiplicity of the inlet opening 64 b provides a cumulatively larger pathway for the urine to pass from the bladder into the passageway 56 of the catheter 20 b .
- Having a multiplicity of inlet openings 64 b rather than a single inlet opening 64 or a pair of inlet openings 64 decreases the possibility that a blood clot will prevent urine from flowing into the interior passageway 56 ( FIG. 3 ) from the bladder 32 , and decreases the possibility of a single clot entering the catheter 20 b and blocking the passageway 56 ( FIG. 3 ).
- urine will flow into the passageway 56 through one or more of the other unobstructed openings 64 b .
- the multiple urine drainage inlet openings 64 b in the catheter 20 b cause it to be referred to as having a multiple opening tip 111 .
- the rounded distal end 38 of the multiple opening tip 111 facilitates the insertion of the catheter 20 b into the urinary canal 36 .
- the indwelling catheter 20 c shown in FIG. 13 has a couvelaire tip 112 .
- the couvelaire tip 112 has a pair of relatively-large elongated or oval-shaped inlet openings 64 c positioned on diametrically opposite sides of the end piece 62 c .
- the enlarged inlet openings 64 c are significantly larger than the inlet openings 62 typically found in a catheter ( FIGS. 2 and 3 ).
- the cross-sectional size of each of the inlet openings 64 c is significantly greater than the cross-sectional size of the interior passageway 56 .
- each inlet opening 64 c is preferably greater than one fourth of the circumferential distance around the main body 58 and the longitudinal dimension of each inlet opening 64 c is greater than the transverse dimension.
- the enlarged size makes it difficult for blood clots to accumulate within the inlet openings 64 c and to obstruct urine flow into and through the interior passageway 56 ( FIG. 3 ).
- the rounded distal end 38 of the couvelaire tip 112 facilitates the insertion of the catheter 20 c into the urinary canal 36 .
- the indwelling catheter 20 d shown in FIG. 14 has a beveled tip 114 .
- the end piece 62 d includes a somewhat flat beveled surface 116 that extends at an acute angle more transversely relative to the axis of the catheter from the distal end 38 of the end piece 62 d than longitudinally.
- a single urine drainage inlet opening 64 d is formed through the beveled surface 116 . Because of the transverse angle of the beveled surface 116 relative to the axis of the catheter 20 , the flow passageway through the inlet opening 64 d more directly aligns with and enters the interior passageway 56 ( FIG. 3 ).
- the single inlet opening 64 d can be made of a size larger than the cross-sectional size of the passageway 56 .
- the more-directly entering flow passageway through the inlet opening 64 d avoids the right angle turn associated with the openings 62 in the end piece 64 ( FIGS. 2 and 3 ).
- the more-directly entering flow passageway through the inlet opening 64 d provides less of an obstruction or restriction for the blood clots to accumulate and to obstruct the passageway 56 .
- the end piece 62 d retains a rounded distal end 38 which facilitates insertion of the catheter 20 d into urinary canal 36 .
- the beveled surface 116 also facilitates insertion of the catheter 20 d into the urinary canal.
- Obstructions from blood clots and other urinary tract matter can also be avoided by incorporating a clearing device 120 within the indwelling catheter 20 e , as shown in FIG. 15 .
- the clearing device 120 is located within the interior passageway 56 of the catheter 20 e and includes an obstruction clearing contact element (e.g., brush structure 122 ) which is movable longitudinally along the interior passageway 56 .
- the obstruction clearing contact element dislodges the blood clots or other obstructions within the passageway 56 , or breaks the blood clots or obstructions into smaller pieces, or breaks open the accumulation of clots or obstructions in the openings 64 , as a result of movement of the clot clearing contact element within the passageway 56 , as shown in FIG. 16 . Dislodging or breaking up the clots and obstructions opens the passageway 56 to the flow of urine and carries the obstructions out of the urinary tract with the flow of urine.
- an obstruction clearing contact element e.g., brush structure
- One form of the contact element of the clearing device 120 utilizes a brush structure 122 formed by a plurality of bristles held together to form the brush structure 122 .
- the brush structure 122 is retained in a stowed position at an internal distal end 124 of the passageway 56 within the end piece 62 , spaced slightly distally from the inlet openings 64 , as shown in FIG. 15 .
- the brush structure 122 is held in the stowed position by bias force from a return spring 126 which extends between the brush structure 122 and the internal distal end 124 of the passageway 56 . In its stowed position, the brush structure 122 does not interfere with the flow of urine through the inlet openings 64 and the interior passageway 56 .
- a thread-like tether 128 is attached to the brush structure 122 and the spring 126 , and the tether 128 extends through the passageway 56 of the catheter 20 e on the opposite side of the brush structure 122 from the return spring 126 .
- the catheter 20 e is attached to the insertion tool 22 ( FIG. 1 )
- the tether 128 extends through the passageway 56 and the interior channel 88 of the insertion tool 22 ( FIG. 10 ) and out of the handle 82 ( FIG. 1 ).
- the insertion tool 22 is disconnected from the indwelling catheter 20 e and the insertion tool 22 is removed in the manner previously described.
- the tether 128 remains in position within the urinary canal 36 as the insertion tool 22 is removed, as a result of the tether 128 moving through the interior channel 88 of the insertion tool.
- the proximal end of the tether 128 remains exterior of the urinary canal 36 .
- the brush structure 122 When it is determined that the urine flow path through the passageway 56 is obstructed by blood clots, the brush structure 122 is moved out of the stowed position ( FIG. 15 ) and is moved longitudinally proximally along the interior passageway 56 by pulling proximal end of the tether 128 at the exterior of the urinary canal 36 , as shown in FIG. 16 .
- the resiliency of the return spring 126 permits proximal longitudinal movement.
- the brush structure 122 moves along the passageway 56 , the blood clots or obstructions are contacted by the brush structure 122 .
- the longitudinal movement of the brush structure dislodges and shears the clots out of the inlet openings 64 and the passageway 56 .
- Deflected bristles of the brush structure 122 within the interior passageway 56 spring outwardly through the inlet openings 64 to push the clots or obstructions out of those inlet openings.
- the bristles of the brush structure 122 also shear or break the clots or obstructions within the inlet openings and the passageway 56 into smaller pieces.
- the dislodged, broken and smaller clots or obstructions flow with the urine through the opened passageway 56 and into the urinary canal 36 , or the movement of the brush structure 122 pushes the clots or obstructions through the passageway 56 out of the catheter 20 e .
- the clots or obstructions thereafter pass through the remaining portion of the urinary canal 36 and out of the body by the flow of urine.
- the tether 128 constitutes one form of an activation device for operating the obstruction clearing device 120 .
- the tether 128 is released and the return spring 126 pulls the brush structure 122 from the position shown in FIG. 16 back into the stowed position at the internal distal end 124 of the passageway 56 shown in FIG. 15 . Thereafter, urine may again flow through the passageway 56 in the normal matter. Should the inlet opening 64 or the passageway 56 again become obstructed, the brush structure 122 can again be moved longitudinally by pulling on the tether 128 to again clear the urine flow path through the inlet openings 64 and the passageway 56 .
- the clearing device 120 can be used as many times as needed in this manner to keep the catheter 20 e open to the flow of urine.
- An alternative form of the clearing device 120 provides for a one-time use to clear the urine flow passageway.
- the return spring 126 is omitted.
- the brush structure 122 is retained in the stowed position ( FIG. 15 ) by frictional forces between the bristles and the inside surface of the passageway 56 at the internal distal end 124 . If the urine flow through the passageway 56 becomes obstructed, the tether 128 is pulled and the brush structure 122 is moved from the stowed position longitudinally through the passageway 56 ( FIG. 16 ), thereby clearing the passageway of clots or obstructions. Continuing to pull the tether 128 removes the brush structure 122 from the interior passageway 56 and into the urinary canal 36 . The clearing device 120 is then pulled completely out of the urinary canal 36 .
- the obstruction is removed at the same time that the brush structure 122 is removed from within the indwelling catheter 20 e .
- the clearing device 120 can only be used once in this manner, a single use may prove satisfactory for those TUMT, heat treatment and other patients for whom blood clots and other obstructions are not expected to be a significant issue.
- the use of the single-use clearing indwelling catheter 20 e may be prescribed if the physician knows or prefers to replace the indwelling catheter 20 e on a periodic basis during healing.
- the clearing device 120 can be used while the insertion tool 22 remains connected to the indwelling catheter 20 e for flushing the catheter 20 .
- the tether 128 extends through the interior channel 88 in the insertion tool 22 and therefore does not interfere with the flow of flushing fluid through the interior channel 88 and into the interior passageway 56 . Clearing the blood clots or obstructions by use of the clearing device 120 in combination with flushing or in alternation with flushing, may be reserved for those situations where flushing by itself is insufficient to eliminate the obstructions.
- Using the clearing device 120 can also enhance the effect of the flushing, by loosening and breaking the clots or obstructions prior to flushing. In this manner, the amount and extent of flushing may be reduced, which can be important in minimizing the discomfort associated with forcing additional flushing fluid into an already-filled bladder.
- Forcing the flushing fluid into the interior channel 88 and interior passageway 56 may also move the brush structure 122 back to the stowed position. In this circumstance, the return spring 126 is not needed to obtain multiple uses of the clearing device 120 . Forcing the flushing fluid into the interior channel 88 and interior passageway 56 may also help to move the brush structure 122 back to the stowed position, thereby assisting the return spring 126 .
- the stowed position of the clearing device 120 is slightly distal of the most distal openings 64 within the interior passageway 56 .
- the clearing device 120 may take a different form from the brush structure 122 or a part of the urine flow may normally pass through the brush structure 122 .
- the different form of the clearing device 120 may permit it to move out of the path of the normal urine flow through the interior passageway 56 yet move across the inlet openings 64 and along the interior passageway 56 in such a way to clear obstructions within the inlet openings. This may be accomplished by rotating and longitudinally moving the clearing device 120 within the interior passageway 56 , rather than solely moving the clearing device 120 longitudinally within the interior passageway 56 . If the inlet openings 64 are sufficiently large, the exposed brush structure 122 may not substantially interfere with normal urine flow, because the size of the inlet opening 64 is so large that the presence of the brush structure 122 at a portion of the inlet openings 64 is not significant. Any clots which might form on the brush structure 120 to itself are broken as the brush structure moves into the interior passageway 56 , while still breaking, sharing and dislodging other obstructions present in the interior passageway.
- enlarged urinary inlet opening configurations of 64 a - 64 d and the clearing device 120 have been shown in connection with a partial-length indwelling catheter, they are also applicable for use in full-length catheters. Use with a full-length catheter occurs in the same manner as occurs while the insertion tool 22 remains connected to the partial length catheter.
- the partial-length catheter allows voluntary natural use of the external urinary sphincter muscle 34 to start and stop urine flow.
- the location of the indwelling catheter within the prostate gland 30 bypasses most of the urine flow from contact with the tissue of the prostate gland 30 which has been affected by the surgical procedure, thereby preventing or lessening pain and irritation.
- Any blood which may accumulate within the interior passageway of the indwelling catheter, and possibly cause obstructions due to clots, is flushed and cleared from the interior of the indwelling catheter prior to removal of the insertion tool 22 .
- the separation of the insertion tool 22 from the indwelling catheter 20 may be delayed until the risks of obstructions from blood clots and the like has passed.
- the indwelling catheter also assures a passageway for urine to flow through a prostate gland 30 that is diseased and swollen from BPH or other diseases.
- the catheter reliably remains in position for use due to the anchoring effects of the inflated balloon 40 and the coiled section 54 , thereby lessening the risk of further surgical procedures to reposition and remove an inadvertently displaced catheter.
- Obstructions blocking the urine flow into and through the catheter, such as blood clots are reduced or eliminated by the low friction coating and the various configurations of the inlet openings 64 at the distal end of the catheter. If the interior passageway 56 does become obstructed, the blood clot or other obstruction clearing device 120 is selectively movable within the passageway 56 to eliminate the obstruction without having to resort to a surgical procedure for replacing the catheter 20 .
Abstract
A catheter for draining urine from a bladder is made more resistant obstructions and blood clot accumulations by configurations of urine inlet openings into an interior urine drainage passageway. The inlet opening configurations include a whistle tip, a multiple opening tip, a couvelaire tip, and a beveled tip with a direct opening into the passageway. A low friction coating also resists blood clot accumulation. A single-use or multiple-use clearing device moves within the interior drainage passageway to contact, disintegrate, and facilitate movement of the accumulated clots and obstructions out of the urine inlet opening and interior passageway.
Description
- This is a continuation in part of U.S. application Ser. No. 10/665,742, filed Sep. 17, 2003, by the inventors hereof and assigned to the assignee hereof. The subject matter of this prior application and invention is incorporated herein by this reference.
- This invention relates to an urinary catheter and the use of an urinary catheter. More particularly, the present invention relates to a new and improved catheter that reduces the incidence of obstructions in the urine flow path through the catheter, such as those arising from blood clots, and to a new and improved catheter that facilitates removing and disintegrating blood clot obstructions should they occur.
- Prostate problems, such as benign prostate hyperplasia (BPH) and malignant prostate cancer, are common occurrences among older men. The effects of these diseases are generally accompanied by swelling or enlargement of the prostate gland. Apart from the life-threatening aspects of malignant prostate cancer, the everyday symptoms and effects of these diseases are usually troublesome. One such problem relates to the ability to control and achieve normal urine discharge. When the prostate gland enlarges to the extent that it obstructs the prostatic urethra through the prostate gland, considerable difficulties arise in discharging urine at will. Such difficulties are typically referred to as urinary tract retention. Urinary tract retention can be either acute or chronic.
- Surgical treatments are available for relieving urinary tract retention problems, e.g. transurethral resection of the prostate (TURP). A TURP procedure involves surgically resecting tissue from the prostate gland to eliminate or reduce obstruction or restriction. Surgical operations offer a high probability of an excellent clinical outcome, but they are associated with a high degree of morbidity. Alternative treatments with milder side-effects include transurethral microwave thermotherapy (TUMT), radio frequency needle ablation (TUNA), interstitial laser and hot water induced thermotherapy (WIT). All of these alternative treatments involve heating the obstructive prostatic tissue until the tissue is destroyed or damaged. Thereafter, the destroyed or damaged tissue sloughs off, is absorbed in the body, and otherwise results in an enlargement of the urinary passageway through the prostate gland. The enlargement of the urinary passageway through the prostate gland eliminates or relieves the obstruction and permits better urine flow. A TURP procedure involves surgically resecting tissue from the prostate gland to eliminate or relieve the obstruction.
- TURP and the different prostate heat treating techniques cause temporary side effects, for example inflammation and swelling of the prostate. The side effects usually require the patient to use an indwelling urine drainage catheter for a few days up to several weeks following the procedure to permit urination while the swelling subsides and the tissue of the prostate gland heals or stabilizes. The tissue of the prostate gland which remains viable after a TUMT or a heat treatment is quite raw and tender, and direct contact from urine can aggravate the inflammation and increase the risk of infection. An indwelling catheter permits the urine to pass through the tissue where the surgical procedure was performed with minimal or no contact with the treated tissue.
- In those cases where the diseased prostate gland cannot be treated by a TURP or a heat treatment, the obstruction may become so significant that normal urinary functions are not possible or are only possible with great difficulty. In these circumstances, it is necessary for a catheter to be used for the rest of the patient's life. In some cases, the patient is taught to insert a full-length catheter whenever urination is necessary. In other cases where the patient cannot insert a full-length catheter himself, medical personnel insert the full-length catheter in the urinary tract where it remains until removal by medical personnel.
- The typical type of urinary catheter used while the prostate gland heals, or on a continual basis, is a full-length urinary catheter. A full-length urinary catheter extends from the exterior opening of the urinary canal through the entire length of the urinary tract into the bladder. A clamp or other mechanical valve at the exterior of the catheter is opened to drain the urine from the bladder and is closed to terminate urination. A reservoir may be attached to the end of the catheter to collect the urine discharge, in which case the mechanical valve and clamp may not be used. The internal urinary sphincter muscle at the bladder neck, which normally controls the flow of urine from the bladder into the prostatic urethra and the remainder of the urinary canal, is no longer able to perform its natural function of constricting the urethra to stop urine flow and dilating to allow urine flow. TURP and heat treatment surgical procedures usually destroy the internal urinary sphincter muscle. Even if not destroyed, neither the internal urinary sphincter muscle, which is located upstream of the prostatic urethra, nor the external urinary sphincter muscle, which is located downstream of the prostatic urethra, can control urine flow because a continuously open urine flow passageway extends through the catheter and these urinary sphincter muscles which cannot close the passageway through the catheter.
- In addition to the patient lacking the ability to naturally control urine flow when using a full-length urinary catheter, the extension of the catheter out of the exterior opening of the urinary canal and the presence of the clamp valve and the reservoir cause discomfort, are awkward to deal with and may be embarrassing for the patient. The full-length urinary catheter may create limitations from a social standpoint and almost always creates quality of life issues which must be confronted. Sexual activity is impossible. An increased risk of infection also results.
- Because of the quality of life and social issues associated with full-length urinary catheters, partial-length indwelling catheters have been developed. Partial-length indwelling catheters typically extend only from the bladder through the prostatic urethra, and not along the entire length of the urinary tract from the bladder to the exterior opening. The reduced length permits the external urinary sphincter muscle to control urine flow in a more natural manner, while still bypassing most of the urine flow around the swollen or raw prostate gland. No sizeable part of the catheter extends out of the exterior opening of the urinary canal.
- Keeping a partial-length indwelling catheter in the proper position is essential. The short length may allow the catheter to move completely into the bladder or move out of the prostatic urethra into the urinary canal. Either type of unintended movement may require serious medical intervention to correct.
- A partial-length urinary catheter typically uses an inflatable balloon or other form of anchor at its end which is innermost within the body and upstream relative to the urine flow. The balloon is expanded, or the anchor is enlarged, within the bladder, and the catheter is then is withdrawn until the balloon or anchor contacts the bladder neck at the entrance to the urethra. The balloon or anchor prevents the catheter from moving out of the bladder and into the urinary canal. However, the balloon cannot prevent the partial-length urinary catheter from moving out of the prostatic urethra and into the bladder.
- One way of preventing a partial-length urinary catheter from moving into the bladder involves attaching a downstream anchor to the partial-length of catheter with a short length of thread-like material. The thread-like material extends through the orifice of the external urinary sphincter muscle, and the downstream anchor is positioned downstream from the external urinary sphincter muscle. The catheter and the anchor tube are positioned in the prostatic urethra and the urinary canal, respectively, on opposite sides of the external urinary sphincter muscle. The external urinary sphincter muscle is able to constrict around the thread-like material to stop urine flow and is able to dilate to permit the flow of urine. The normal constricted state of the external urinary sphincter muscle adjacent to the anchor tube prevents the partial-length catheter from moving into the bladder.
- Treatment of the prostate gland with a TUMT or a heat treatment usually causes the destruction of the bladder neck and results in blood clots which enter the bladder. These clots float in the urine in the bladder and enter the catheter where they can accumulate to the extent of obstructing the flow of urine through the catheter. If the patient is unable to clear the clot accumulation by urinating, then the catheter must be medically removed and replaced. Replacement of the catheter shortly after treatment causes irritation to the treatment area, can be painful for the patient, typically prolongs of the healing time period, and creates greater medical expense if the catheter must be removed and replaced. The problems of possible obstructions from blood clots are equally applicable to full-length and partial-length catheters.
- Another possibility of blockage of the catheter is due to obstructions from other natural body substances in the bladder or the urine. While such risks are not as significant as those risks which arise because of blood clots after a surgical procedure, such risks are nevertheless significant for those individuals who must utilize an urinary catheter on a full-time basis, because of the continual possibility of obstruction to the urine passageway through the catheter.
- In general, the present invention pertains to a full-length or partial-length urinary catheter which extends from the bladder through the urinary tract to the exterior opening of the urinary canal. The catheter resists the accumulation of blood clots and obstructions within an interior urine drainage passageway of the catheter, thereby maintaining the urine drainage capability of the passageway through the catheter. The catheter is beneficial in avoiding entirely or reducing the number of instances where a medical or surgical procedure is required to remove and replace the entire catheter. The catheter also promotes better healing of the prostate gland after surgery because of the continually open urine drainage passageway which conducts the urine away from the surgically-affected area and thereby reduces the risk of infection and irritation.
- These and other improvements and advantages are achieved by a catheter used to drain urine from a bladder to a location adjacent to an external urinary sphincter muscle of an urinary tract. The urinary tract includes an urinary canal extending from the external urinary sphincter muscle to an exterior opening of the urinary canal. An inlet opening is located in the distal end of the catheter and has a configuration which facilitates passing urine and blood clots from the bladder into an interior urine drainage passageway of the catheter. The configuration of the inlet opening reduces blood clot accumulation and other urine flow obstructions.
- The inlet opening may assume different beneficial alternative configurations. The urinary opening may be defined by the absence of a longitudinal half portion of a rounded tip and a distal end portion of the catheter adjacent to the rounded tip established by longitudinally bisecting the rounded tip. The longitudinal half portion is established by longitudinally bisecting the rounded tip and the distal end portion adjoining the rounded tip. A whistle-tip shape results from this configuration. The inlet opening may be defined by a plurality of separate openings, each of which is spaced from an adjacent separate opening along the distal end portion adjacent to the rounded tip. Each of the separate openings communicates with the interior urine drainage passageway in the catheter. The inlet opening may be defined by two radially opposite openings having a transverse dimension greater than one fourth of the circumferential distance around the main body and a cross-sectional size substantially greater than the cross-sectional size of the interior passageway of the catheter. A couvelaire tip results from this configuration. The inlet opening may be defined by a substantially direct opening through a beveled tip of the catheter. The direct opening substantially aligns with the interior passageway of the main body and has a cross-sectional size at least equal to the cross-sectional size of the interior passageway. In addition to the inlet opening configurations, the catheter may include a low friction coating over the distal end, within the inlet opening, and along the interior passageway, to resist the attachment and the accumulation of blood clots and other obstructions.
- The catheter may also incorporate a clearing device within the internal urine drainage passageway of the catheter. The clearing device includes a contact element normally located in a stowed position at a distal end of the interior passageway. The contact element moves within the interior passageway from the stowed position past the inlet opening and along the interior passageway to a position downstream of the inlet opening in the urine flow path through the catheter. The movement of the contact element into contact with blood clots or other obstructions in the inlet opening and in the interior passageway disintegrates the blood clot accumulations and obstructions and facilitates passage of the clots and obstructions through the catheter with urine flow. Preferably, an activation device is connected to the contact element, and the activation device extends through the urinary canal to a position outside of the exterior opening of the urinary canal. Manipulation of the activation device at the position outside of the exterior opening of the urinary canal moves the contact element to disintegrate the blood clot accumulations and other obstructions and facilitates passage of the clots and obstructions through the interior passageway with the urine.
- A more complete appreciation of the scope of the present invention and the manner in which it achieves the above-noted and other improvements can be obtained by reference to the following detailed description of presently preferred embodiments taken in connection with the accompanying drawings, which are briefly summarized below, and by reference to the appended claims.
-
FIG. 1 is a perspective view of an indwelling prostatic catheter which incorporates the present invention, shown attached to an insertion tool and used with a syringe. -
FIG. 2 is an enlarged perspective view of the indwelling prostatic catheter shown inFIG. 1 with the insertion tool removed and with a balloon of the indwelling catheter expanded. -
FIG. 3 is an enlarged longitudinal cross-section view taken substantially in a longitudinal axial plane throughFIG. 2 . -
FIG. 4 is an enlarged transverse cross-section view taken substantially in the plane of line 4-4 ofFIG. 1 . -
FIG. 5 is an enlarged partial longitudinal axial cross-section view of a separable connection of the indwelling catheter-insertion tool assembly shown inFIG. 1 , taken substantially in the plane of line 5-5 shown ofFIG. 1 . -
FIG. 6 is a perspective view of the indwelling catheter and a portion of the insertion tool shown inFIG. 1 , shown inserted within a urethra, a urethra sphincter, a prostatic urethra and a bladder of an urinary tract of a human being, with the physiology generally illustrated in cross section. -
FIG. 7 is an illustration similar toFIG. 6 showing the balloon inflated within the bladder. -
FIG. 8 is an illustration similar toFIGS. 6 and 7 showing separation of the insertion tool from the indwelling catheter. -
FIG. 9 is an illustration similar toFIGS. 6-8 showing the position and use of the indwelling catheter. -
FIG. 10 is a partial, enlarged and broken view of the catheter-insertion tool assembly shown inFIG. 1 , illustrating an alternative embodiment of the separable connection shown inFIG. 5 , and other aspects of the invention. -
FIG. 11 is a perspective view of an indwelling catheter similar to that shown inFIG. 2 with a different distal end configuration. -
FIG. 12 is a perspective view of an indwelling catheter similar to that shown inFIG. 11 with another distal end configuration. -
FIG. 13 is a perspective view of an indwelling catheter similar to that shown inFIGS. 11 and 12 with still another distal end configuration. -
FIG. 14 is a perspective view of an indwelling catheter similar to that shown inFIGS. 11-13 with a further distal end configuration. -
FIG. 15 is a cross-section view of an indwelling catheter similar to that shown inFIG. 3 which further includes an obstruction clearing device located in a stowed position. -
FIG. 16 is a cross-section view similar to that shown inFIG. 15 , showing the clearing device moved longitudinally within an interior passageway of the catheter from the position shown inFIG. 15 to an operative position which clears obstructions. - A partial-length
indwelling catheter 20 which incorporates the present invention is shown inFIG. 1 , but the present invention is also applicable to full-length catheters (not shown). The indwellingcatheter 20 is connected to aninsertion tool 22, to form a catheter-tool assembly 24, which allows thecatheter 20 to be inserted into anurinary tract 26 of a human being, as shown inFIG. 6 . Once inserted, theinsertion tool 22 is disconnected or separated from the indwellingcatheter 20 to leave thecatheter 20 dwelling or remaining within aprostatic urethra 28 within aprostate gland 30, as shown inFIG. 9 . In its indwelling use position shown inFIGS. 8 and 9 , thecatheter 20 drains urine from abladder 32 through theprostatic urethra 28 within theprostate gland 30 to a position slightly upstream of an externalurinary sphincter muscle 34. When the externalurinary sphincter muscle 34 dilates, the urine drains through an orifice of the the externalurinary sphincter muscle 34 and into anurinary canal 36 of theurinary tract 26. - The
catheter 20 will typically be left in the indwelling position shown inFIG. 9 for a number of days or weeks to function as a temporary stent to protect raw tissue of theprostate gland 30, after it has been operated on to remove portions of theprostatic urethra 28 and the surrounding tissue of theprostate gland 30 in a transurethral resection of the prostate (TURP) surgical procedure, or after these tissues have been destroyed or operated on by a microwave thermotherapy treatment (TUMT) or other thermotherapy treatment. In addition, thecatheter 20 can also be used as a stent through theprostatic urethra 28 when it has been constricted to the point where urine will no longer pass effectively as a result of swelling in theprostate gland 30 due to benign prostate hyperplasia (BPH) or other obstructions or abnormalities. There are other medically-recognized reasons to use theindwelling catheter 20. - The indwelling
catheter 20 is positioned as shown inFIG. 9 by pushing thecatheter 20 into theurinary tract 26 with theinsertion tool 22 until adistal end 38 of theindwelling catheter 20 enters thebladder 32 as shown inFIG. 6 . Aballoon 40 on theindwelling catheter 20 is inflated with fluid conducted through aninflation passageway 42 of an inflation tube 44 (FIG. 3 ) until theballoon 40 is larger in diameter than aneck 46 of thebladder 32 surrounding theprostatic urethra 28. The inflation fluid may be gas, such as air, or liquid such as saline solution. Theballoon 40 is preferably inflated from an inflation pump such as asyringe 48 which is connected to avalve assembly 50 at the end of the inflation tube 44 (FIG. 1 ). Once theballoon 40 has been inflated, theinsertion tool 22 is pulled backward until theinflated balloon 40 is seated on thebladder neck 46, as shown inFIG. 7 . When seated on thebladder neck 46, theballoon 40 prevents theindwelling catheter 20 from moving out of thebladder 32, through the externalurinary sphincter muscle 34 and into theurinary canal 36. - Continued withdrawal movement of the
insertion tool 22 causes it to separate from thecatheter 20 at a separable connection 52 (FIG. 1 ) between theindwelling catheter 20 and theinsertion tool 22 as shown inFIG. 8 , thereby leaving theindwelling catheter 20 in its final, indwelling position shown inFIG. 9 . Theinsertion tool 22 is thereafter withdrawn and removed from within theurinary canal 36. Theinflation tube 44 remains within theurinary canal 36. - The relative terms “proximal” and “distal” are used in this description in relation to the medical practitioner who inserts the
catheter 20 into theurinary tract 26 at the exterior opening of theurinary canal 36. Accordingly, the portions of thecatheter 20 which are the most internal within the patient are referred to as “distal,” and the portions of thecatheter 20 which are closest to the exterior opening of theurinary canal 36 are referred to as “proximal.” The distal portions of the catheter are therefore located more interiorly within theurinary tract 26 than are the proximal portions of the catheter. The distal portions of the catheter are upstream relative to the normal direction of urine flow, and the proximal portions of the catheter are downstream relative to the normal direction of urine flow. Theballoon 40 is located near the distal end of thecatheter 20, and a distal end of theinflation tube 44 connects to a proximal end of amain body 58 of thecatheter 20 at a location upstream or distal of the externalurinary sphincter muscle 34. - The
inflation tube 44 is formed with a permanently helically coiledsection 54 shown inFIGS. 1-3 and 6-9. The coiledsection 54 is resilient both in the transverse dimension and in the longitudinal dimension. Theinflation tube 44 has sufficient strength to maintain the coiledsection 54 in the coiled configuration within theurinary canal 36 after removal of theinsertion tool 22. Because of the resiliency of the coiledsection 54, the coiledsection 54 presses against the interior of theurinary canal 36. The orifice through theexternal sphincter 34 is normally closed except during urination thus preventing the coiledsection 54 from migrating distally or upstream past theexternal sphincter 34. In this way, the coiledsection 54 resists movement along theurinary canal 36 to hold theindwelling catheter 20 from moving along theurinary canal 36. By resiliently pressing against the interior of theurinary canal 36, the coiledsection 54 also minimizes discomfort to the patient or irritation to theurinary canal 36. The coiledsection 54 is not disruptive to the flow of urine through theurinary canal 36 because the coiledsection 54 provides a fluid-flow path through an open center of the coils. - With the
catheter 20 connected to theinsertion tool 22, the coiledsection 54 extends around the exterior of theinsertion tool 22, as shown inFIG. 4 . By extending around the exterior of theinsertion tool 22, the coiledsection 54 assists in holding theinflation tube 44 adjacent to theinsertion tool 22 while theindwelling catheter 20 and theinsertion tool 22 are inserted in theurinary tract 26. The coiledsection 54 therefore assists in moving theinflation tube 44 into theurinary tract 26 along with theinsertion tool 22. The helically coiledsection 54 is loosely wound around theinsertion tool 22, thereby allowing theinsertion tool 22 to be withdrawn through the center of the coiledsection 54 as theinsertion tool 22 is disconnected from the indwellingcatheter 20. - The coiled
section 54 is located a short distance proximally from the proximal end of the main body of theindwelling catheter 20. The length of theinflation tube 44 between the proximal end of theindwelling catheter 20 and the coiledsection 54 is sufficient to locate the coiledsection 54 within theurinary canal 36 at a position slightly proximal of theurinary sphincter muscle 34, as shown inFIGS. 6-9 . - Located slightly proximally of the
urinary sphincter muscle 34, the coiledsection 54 of theinflation tube 44 functions as an anchor to assist in holding theindwelling catheter 20 in theurinary tract 26 in the position shown inFIG. 9 . The coiledsection 54 prevents theindwelling catheter 20 from moving distally from the position shown inFIG. 9 , as a result of the coils of the coiledsection 54 contacting a constriction in the urinary tract caused by constriction of thesphincter muscle 34. The coiledsection 54 contacts the constriction to resist the distal movement of theindwelling catheter 20 and to prevent it from moving into thebladder 32. Theinflated balloon 40 creates a restriction at thedistal end 38 of theindwelling catheter 20 to prevent it from moving proximally along theurinary tract 26 and out of theurinary canal 36. With the inflatedballoon 40 located at the distal end of theindwelling catheter 20 and the anchoring coiledsection 54 located on the proximal side of thesphincter muscle 34, the indwellingcatheter 20 resists movement either into or out of thebladder 32 and out of the prostatic urethra. Instead, the indwellingcatheter 20 is maintained in the use position. - With the
indwelling catheter 20 in the use position anchored by theballoon 40 and the coiledsection 54, urine or other fluid from thebladder 32 is able to flow through an interior passageway 56 (FIG. 3 ) in theindwelling catheter 20 and out of the proximal end of thecatheter 20 past the dilated urinary sphincter muscle 34 (FIG. 9 ). The externalurinary sphincter muscle 34 retains the capability to constrict or close around theinflation tube 44 to stop the urine flow. The urine is discharged into theurinary canal 36 in the normal manner. The final indwelling use position of thecatheter 20 permits normal control by the externalurinary sphincter muscle 34 over urine flow. - More details concerning the structure of the
indwelling catheter 20 are illustrated inFIGS. 1-5 . The indwellingcatheter 20 includes a main orcentral body 58, preferably made from silicone rubber. Themain body 58 has a generally cylindrical exterior shape. Themain body 58 includes asidewall 60 which defines thepassageway 56 through themain body 58. Anend piece 62 is either attached to or integral with themain body 58 at thedistal end 38 of thecatheter 20. Theend piece 62 has a tip configuration adapted to facilitate insertion of thecatheter 20 and theinsertion tool 22 into theurinary tract 26. At least one and preferably a pair ofurine inlet openings 64 are formed through theend piece 62. Theopenings 64 communicate between the exterior of theend piece 62 and thepassageway 56 of themain body 58. Urine from thebladder 32 flows through theopenings 64 and into and through thepassageway 56 to the other proximal end of themain body 58. - The
balloon 40 is formed by aflexible sleeve 66 of relatively thin, flexible, expandable, usually-transparent and non-porous material which is attached with fluid-tight seals main body 36. A first fluid-tight seal 68 is located slightly proximally of the distal end of themain body 58 where theend piece 62 is attached, and a second fluid-tight seal 70 is spaced proximally along themain body 58 from thefirst seal 68 by a distance approximately equal to the axial length of theflexible sleeve 66. The fluid-tight seals flexible sleeve 66 to themain body 58 with an adhesive or by thermal welding. - The
flexible sleeve 66 is positioned over the top of and extends axially on opposite sides of anopening 72 from themain body 58. The fluid-tight seals opening 72, respectively. Fluid is introduced into avolume 74 at the exterior of themain body 58 between the fluid-tight seals flexible sleeve 66, causing theflexible sleeve 66 to expand outward and create theballoon 40. - An
inflation conduit 76 communicates with theopening 72, as shown inFIG. 3 . Theinflation conduit 76 is formed within thesidewall 60 of themain body 58. A distal end of theinflation tube 44 is inserted into a proximal end of theinflation conduit 76, as shown inFIGS. 3 and 5 . The fluid is delivered from the syringe 48 (FIG. 1 ) into theinflation passageway 42 of theinflation tube 44 and flows into theinflation conduit 76, out of theopening 72 and into thevolume 74 beneath theflexible sleeve 66, causing theflexible sleeve 66 to expand into the form of theballoon 40. - Inserting the distal end of the
inflation tube 44 into theinflation conduit 76, as shown inFIG. 5 , allows theinflation tube 44 to bypass or go around theseparable connection 52 between theindwelling catheter 20 and theinsertion tool 22. A strong fluid-tight bond is formed by attaching theinflation tube 44 into theinflation conduit 76 with an adhesive. The attachment maintains theinflation tube 44 connected to the main body so that pulling on the inflation tube from the exterior of theurinary canal 36 will remove thecatheter 20 from theurinary tract 26 without theinflation tube 44 breaking away from themain body 58. In this regard theinflation tube 44 also serves as a tether for thecatheter 20. Theseparable connection 52 shown inFIG. 5 permits the communication between theinflation passageway 42 and theinflation conduit 76 to remain intact and fluid tight after theinsertion tool 22 has separated from the indwellingcatheter 20 while thecatheter 20 remains positioned within the urinary tract. The continued integrity of the inflation passageway between theballoon 40 and thevalve assembly 50 allows theballoon 40 to be periodically reinflated while theindwelling catheter 20 is in use, if necessary. Periodic reinflation may be necessary as a result of minute leaks in theballoon 40, thevalve assembly 50 or the passageways connecting theballoon 40 and thevalve assembly 50. - The
inflation tube 44 has a length which extends from themain body 58 of theindwelling catheter 20 through theurinary canal 36 to the outside of the human body. The length of theinflation tube 44 is sufficient to position thevalve assembly 50 at the exterior of the human body. Theinflation tube 44 has sufficient rigidity to prevent theinflation passageway 42 within thetube 44 from collapsing from contact with the tissue of theurinary tract 26, but the rigidity is not so great as to prevent a moderate amount of flexibility in theinflation tube 44. The moderate flexibility of theinflation tube 44 allows it to extend through the typical curves of theurinary tract 26. - The
valve assembly 50 is of a conventional construction and includes areceptacle 78 into which anozzle 80 of thesyringe 48 is inserted, as shown inFIG. 1 . Thevalve assembly 50 also includes a conventional internal check valve (not shown) which closes theinflation passageway 42 at thevalve assembly 50 when thenozzle 80 is removed from thereceptacle 78. In this manner, fluid from within theballoon 40 is prevented from escaping through theinflation passageway 42 when thesyringe 48 is disconnected from thevalve assembly 50, but the check valve permits fluid from thesyringe 48 to inflate theballoon 40 when a plunger (not specifically shown) of thesyringe 48 is depressed. Thus, theballoon 40 will remain inflated after thesyringe 48 is disconnected from thevalve assembly 50. However, should theballoon 40 need to be reinflated or should additional fluid need to be added to expand theballoon 40 during use of the catheter, thesyringe 48 is easily connected to thevalve assembly 50 for doing so. - As an alternative to the use of the
valve assembly 50, theinflation passageway 42 can be sealed at a proximal end after theballoon 40 has been inflated. For example, instead of using thevalve assembly 50 to prevent fluid from escaping from the balloon, a knot may be tied or an obstruction formed (neither shown) in the proximal end of theinflation tube 44 at a location spaced proximally from the end of the penis at the external opening of the urinary canal. The knot or obstruction seals theinflation passageway 42 and prevents the fluid from escaping through the passageway to maintain theballoon 40 inflated. Theinflation tube 42 is cut at a position slightly proximally of the knot or obstruction. In this alternative configuration, theinflation tube 44 without thevalve assembly 50 extends only a modest distance from the open end of theurinary canal 36. Greater comfort and convenience is promoted because there is no sizable apparatus to deal with, such as thevalve assembly 50 connected to the proximal end of theinflation tube 44. If theballoon 40 needs to be reinflated or have additional fluid added after theindwelling catheter 20 has been used for some time, the knot or obstruction can be cut from the end of theinflation tube 44 and a suitable connector attached to allow thesyringe 48 to introduce additional fluid. After suitable inflation, another knot can be tied or an obstruction formed in the remaining proximal portion of theinflation tube 40. Releasing the fluid through theinflation passageway 42 collapses theballoon 40 and allows thecatheter 20 to be pulled out of theurinary canal 36 by pulling on theinflation tube 44. - The
insertion tool 22 is a flexible tubular structure and is generally configured similar to the distal portion of a typical full-length urinary catheter. Theinsertion tool 22 is at least long enough to extend from outside of the body into theurinary canal 36 andprostatic urethra 28 to a point that will place the indwellingcatheter 20 in the final desired use position. Theinsertion tool 22 is preferably made from silicone rubber, but has sufficient structural integrity to transfer pushing forces supplied from the outside of the body longitudinally along the length of theinsertion tool 22, thereby allowing theinsertion tool 22 with the attached indwellingcatheter 20 to be moved distally into theurinary tract 26. A proximal end of theinsertion tool 22 may take the form of ahollow handle 82 or enlargement, by which to grip theinsertion tool 22 and apply pushing force to it during insertion in theurinary tract 26. - The
separable connection 52 between theinsertion tool 22 and theindwelling catheter 20 includes asleeve 84, shown inFIG. 5 . Thesleeve 84 is rigidly connected to the distal end of theinsertion tool 22 by an adhesive, for example. A distal portion of thesleeve 84 projects beyond the distal end of theinsertion tool 22 and into theinterior passageway 56 of the catheter. The distal portion of thesleeve 84 has an exterior diameter which frictionally fits within theinterior passageway 56, and the friction created by the insertion of thesleeve 84 into theinterior passageway 56 is sufficient to retain theindwelling catheter 20 to theinsertion tool 22 during manipulation of the catheter-tool assembly 24 within theurinary tract 26 during insertion and placement, prior to inflation of theballoon 40. However, the degree of frictional resistance between the distal end of thesleeve 84 and themain body 58 at the proximal end of theinterior passageway 56 is not so great as to prevent theindwelling catheter 20 from separating from theinsertion tool 22 once theballoon 40 has been inflated and seated against thebladder neck 46. The amount of frictional resistance between the distal portion of thesleeve 84 and the proximal end of themain body 58 at the proximal end of theinterior passageway 56 can be increased by forming serrations on the exterior of the distal end of thesleeve 84. The resilient material of themain body 58 will deform slightly around the serrations to further assist in holding theindwelling catheter 20 to theinsertion tool 22, but the amount of deformation is not so great as to prevent separation of theindwelling catheter 20 and theinsertion tool 22 at theseparable connection 52. Thesleeve 84 has acenter opening 86 formed through it to provide a fluid flow path from thepassageway 56 through thesleeve 84. - The catheter-
tool assembly 24 is inserted and used in the manner illustrated inFIGS. 6-9 . As shown inFIG. 6 , thecatheter 20 and theinsertion tool 22 are inserted into theurinary tract 26 through theurinary canal 36, in a manner similar to the way that a conventional full-length urinary catheter would be inserted. The insertion force is applied by pushing on theinsertion tool 22 and on thehandle 82 attached at its proximal end. Distal movement of the catheter-tool assembly 24 continues until therounded end piece 62 and a significant distal portion of theindwelling catheter 20 are located in thebladder 32. The insertion is sufficient to assure that theflexible sleeve 66 will be located within thebladder 32. To assure sufficient insertion, it is frequently the case that the distal movement continues until terminated when theend 38 contacts the opposite wall of thebladder 32, thereby assuring that theballoon 40 is within thebladder 32. During insertion in this manner, the coiledsection 54, which is wrapped around theinsertion tool 22, helps keep the forward or distal portion of theinflation tube 44 aligned with and progressing with theindwelling catheter 20. - Once the catheter-
tool assembly 24 has been inserted sufficiently, theballoon 40 is inflated as shown inFIG. 7 . Inflation is achieved by connecting thesyringe 48 to thevalve assembly 50, and depressing the plunger (not shown) of thesyringe 48 to force fluid through theinflation passageway 42 of theinflation tube 44, into theinflation conduit 76, through theopening 72 and into theinterior volume 74, causing theflexible sleeve 66 to expand into theballoon 40. After theballoon 40 is in the expanded position, theinsertion tool 22 is pulled to move the catheter-tool assembly 24 in the proximal direction until theinflated balloon 40 seats against thebladder neck 46. - With the
balloon 40 seated against thebladder neck 46, continued proximal movement of theinsertion tool 22 causes theseparable connection 52 to separate theindwelling catheter 20 from theinsertion tool 22, as shown inFIG. 8 . Theballoon 40 prevents theindwelling catheter 20 from coming out of theurinary tract 26 with theinsertion tool 22 because the expandedballoon 40 is larger than thebladder neck 46. The coiledsection 54 of theinflation tube 44, being located proximally from the externalurinary sphincter muscle 34, prevents theindwelling catheter 20 from moving into thebladder 32. The continued withdrawal of theinsertion tool 22 is not inhibited by the coiledsection 54, because the body of theinsertion tool 22 moves through the interior of the coiledsection 54. The length of theinflation tube 44 is sufficient to locate thevalve assembly 50 at the exterior of theurinary tract 26. - After the
insertion tool 22 is removed as shown inFIG. 9 , theballoon 40 remains inflated in thebladder 32, and the proximal end of themain body 58 of theindwelling catheter 20 extends through theprostatic urethra 28 but does not extend through the externalurinary sphincter muscle 34. The coiledsection 54 is located on the opposite or proximal side of the externalurinary sphincter muscle 34. In this final position, theballoon 40 prevents theindwelling catheter 20 from moving out of theprostatic urethra 28 and into theurinary canal 36, while the coiledsection 54 prevents theindwelling catheter 20 from moving out of theprostatic urethra 28 and into thebladder 32. Theinflation tube 44 does not interfere with the ability of theurinary sphincter muscle 34 to constrict around theinflation tube 44 and naturally stop the urine flow. Similarly, theinflation tube 44 does not interfere with the natural ability of the externalurinary sphincter muscle 34 to dilate, as shown inFIG. 9 , and thereby naturally allow urine to flow through theinterior passageway 56 of theindwelling catheter 20 and into theurinary canal 36. In this manner, theinflation tube 44 does not interfere with the natural control functions of the externalurinary sphincter muscle 34. - When the
urinary sphincter muscle 34 is dilated, the urine flows from thebladder 32 through theopenings 64 and into theinterior passageway 56 in themain body 58, as understood fromFIG. 3 . The flow of urine through theinterior passageway 56 largely bypasses theprostatic urethra 28 or the prostate gland tissue if theprostatic urethra 28 has been removed by a surgical procedure. The dilated urinary sphincter muscle 34 (FIG. 9 ) allows urine to flow from theinterior passageway 56 of theindwelling catheter 20 through theurinary canal 36 in the normal manner. Constriction of theurinary sphincter muscle 34 around theinflation tube 44 stops the urine flow. - While the
urinary sphincter muscle 34 is dilated to permit urine flow, theballoon 40 prevents theindwelling catheter 20 from exiting thebladder 32 and moving into the dilatedurinary sphincter muscle 34. The contact of the coiledsection 54 against the urethra of theurinary canal 36 resists movement of theindwelling catheter 20 into and out of thebladder 32. In addition, theinflation tube 44 can be held at thevalve assembly 50 to resist distal movement of theindwelling catheter 20 during urination when theurinary sphincter muscle 34 is dilated, if necessary or desirable. In this manner, the indwellingcatheter 20 stays in position even when theurinary sphincter muscle 34 is dilated. - When the
indwelling catheter 20 is no longer needed, typically as a result of natural healing of theprostate gland 30 after a surgical or heat treatment procedure, or if it is necessary to periodically replace theindwelling catheter 20, removal is accomplished after deflating theballoon 40. Deflation is accomplished by inserting thesyringe 48 into thevalve assembly 50 and moving the plunger (not shown) of thesyringe 48 outward to withdraw fluid from theinflation passageway 42. The insertion of thesyringe 48 in thevalve assembly 50 opens the check valve within thevalve assembly 50 and allows the fluid to be withdrawn. If theinflation tube 44 has been tied into a knot or an obstruction has been formed to avoid use of thevalve assembly 50 in the manner described above, theinflation tube 44 may be cut at a location distal of the knot or obstruction to allow the fluid to escape. The escaping fluid causes theballoon 40 to deflate, and theflexible sleeve 66 moves to a collapsed position (shown inFIGS. 1 and 6 ) adjacent to themain body 58 of theindwelling catheter 20. - Once the
balloon 40 has been deflated, theinflation tube 44 is pulled outward by gripping and pulling on thevalve assembly 50 or the proximal end of theinflation tube 44. Force is transferred through theinflation tube 44 to themain body 58 of theindwelling catheter 20. The pulling force constricts and elongates the coils of the coiledsection 54, thereby reducing their transverse dimension as a result of longitudinally separating the individual coils with the pulling force. The reduced transverse dimension lessens or eliminates contact with theurinary canal 36. In this manner the coiled section does not inhibit removal of the catheter or induce significant discomfort as it moves through the urinary canal. The amount of force transferred is sufficient to move themain body 58 of theindwelling catheter 20 past theurinary sphincter muscle 34 and into theurinary canal 36. The deflatedballoon 40 does not resist movement of the distal end of theindwelling catheter 20 through thebladder neck 46. Continued pulling movement on theinflation tube 44 moves theindwelling catheter 20 through theurinary canal 36 until theindwelling catheter 20 is completely withdrawn from the proximal end of theurinary canal 36. - In many TUMT and heat treatment procedures, blood from the affected tissue tends to accumulate in the bladder. The blood flows out of the bladder during natural urination. With the
indwelling catheter 20 located in the use position described above, blood could clot within theinterior passageway 56 of theindwelling catheter 20 or blood clots may accumulate to the degree that theinterior passageway 56 oropenings 64 are blocked or obstructed. Natural pressure from the bladder may be insufficient to overcome the blockage, thereby preventing urine flow from thebladder 32 through thecatheter 20. Under such circumstances, it is necessary to remove the obstructed catheter and insert a new catheter, in the manner described above. Replacing an obstructed catheter is to be avoided if possible, because the removal and insertion further aggravates the already-tender tissue within the prostate gland that has been affected by the surgical procedure. - One approach which avoids replacing the catheter under circumstances where blood clots accumulate in the
interior passageway 56 is to flush theinterior passageway 56 with saline or other appropriate liquid on a periodic basis. To do so, it is necessary to establish fluid communication through theurinary canal 36, the constricted externalurinary sphincter muscle 34 and into theinterior passageway 56 of thecatheter 20. The most direct manner of establishing this type of fluid communication is to maintain theinsertion tool 22 connected to theindwelling catheter 20, so that the flushing fluid can be supplied through aninterior channel 88 of theinsertion tool 22 from thehandle 82, as understood fromFIG. 10 . The flushing fluid passes through theinterior channel 88 and through the center opening 86 of thesleeve 84 and into thepassageway 56 of theindwelling catheter 20. The flushing fluid forces any blood clots which accumulated in theinterior passageway 56 back into the bladder 32 (FIG. 6 ) or dissolves the clots within theinterior passageway 56. Removing the clots relieves the obstruction and allows urine to flow through the indwelling catheter in the manner described. - Until the affected tissue stops bleeding, there is a risk that the clots will continue to form within the
passageway 56. The risks of obstruction from blood clots is normally the greatest within the first twenty-four hours after a TUMT or heat treatment procedure. During this time period, it is desirable to provide the ability to flush theinterior passageway 56. To provide the ability to flush the interior passageway, theinsertion tool 22 must remain connected to theindwelling catheter 20 during this time so that theinterior channel 88 of theinsertion tool 22 remains in fluid communication with theinterior passageway 56, through the center opening 86 of thesleeve 84. - Instead of pulling the
insertion tool 22 in the proximal direction to separate theinsertion tool 22 from the indwellingcatheter 20 at theseparable connection 52 after the indwelling catheter has been located in the use position (FIG. 8 ), theinsertion tool 22 may be left in place for approximately the first twenty-four hours. The natural friction between the proximal end of themain body 58 of theindwelling catheter 20 and the distal portion of thesleeve 84 connected to theinsertion tool 22 may be sufficient to maintain theinsertion tool 22 connected to the indwelling catheter in some circumstances. However in other circumstances, the patient may be released from the supervision of medical personnel immediately after the procedure and will be ambulatory during the first twenty-four hour period after the procedure. Movement of the patient under these circumstances may tend to create enough force on theinsertion tool 22 to disconnect the insertion tool from the indwelling catheter prematurely before the risk of blood clots has subsided. - To assure that the
insertion tool 22 remains connected to theindwelling catheter 20 at theseparable connection 52 until medical personnel determines that it is appropriate to separate theindwelling catheter 20 from theinsertion tool 22, a bridging structure, preferably in the form of a relatively fine thread-like cord 90, is used to maintain temporarily theseparable connection 52 of theindwelling catheter 20 and theinsertion tool 22, as shown inFIG. 10 . Thecord 90 extends from theinterior passageway 56 through a small hole 92 in thesidewall 60 of themain body 58 of theindwelling catheter 20. From the hole 92, thecord 90 extends across and bridges theseparable connection 52 along an outside surface of themain body 58 of the indwelling catheter and along an outside surface of a tubularmain body 98 of theinsertion tool 22. The cord also extends through anothersmall hole 94 in asidewall 96 of a maintubular body 98 of theinsertion tool 22, and into theinterior channel 88. The two opposite free-end portions of thecord 90 extend along the length of theinterior channel 88 and terminate within the hollow interior of thehandle 82. The terminal end portions of thecord 90 each loop throughsmall holes sidewall 104 of amain body 106 of thehandle 82.Knots 108 are formed in the terminal end portions of thecord 90 within the hollow interior of thehandle 82 to hold each end of thecord 90 in place relative to thehandle 82. - Any slack longitudinal length of the
cord 90 is eliminated when theknots 108 are tied in the terminal ends of thecord 90. Eliminating any longitudinal slack in thecord 90 pulls together the proximal end of theindwelling catheter 20 and the distal end of theinsertion tool 22. Thecord 90 therefore prevents theindwelling catheter 20 from separating from theinsertion tool 22 at theseparable connection 52. The communication channel through theinterior channel 88, the center opening 86 of thesleeve 84 and theinterior passageway 56 is maintained so long as thecord 90 connects theindwelling catheter 20 and theinsertion tool 22. - While the indwelling
catheter 20 is maintained connected to theinsertion tool 22, flushing fluid may be forced from thehandle 82 through theinterior channel 88, through thecenter opening 86 and into theinterior passageway 56. The flushing fluid dissolves any clots within theinterior passageway 56, and keeps thepassageway 56 unobstructed for urine flow from the bladder. The dissolved clots may flow from theinterior passageway 56 through theinterior channel 88, or the clots may be pushed back into the bladder with the flushing fluid. Of course, while the open communication path exists through theinsertion tool 22 and theindwelling catheter 20, urine from the bladder will also flow through this open path. To control the urine flow under these circumstances, it is necessary to insert a valve in theinterior channel 88 at thehandle 82, to control the discharge of the urine. The extension of theinsertion tool 22 through thesphincter muscle 34 prevents the sphincter muscle from naturally controlling the urine flow. - When it is determined that the risk of blood clots has diminished and it is no longer necessary or desirable to flush the
interior passageway 56 of theindwelling catheter 20, preferably at least twenty-four hours after the procedure, one or both of theknots 108 is untied or cut. One end of thecord 90 is pulled in the proximal direction, which moves the other free end of the cord into theinterior channel 88, through theholes 92 and 94 and then out of theinterior channel 88, thereby disconnecting theindwelling catheter 20 from theinsertion tool 22 at theseparable connection 50. Once thecord 90 no longer holds the indwelling catheter and the insertion tool together as shown inFIG. 10 , theinsertion tool 22 is pulled in the proximal direction to separate it from the indwellingcatheter 20 in the manner previously described and shown inFIG. 8 . The indwellingcatheter 20 remains in the use position shown inFIG. 9 . - The resistance to clotting, both before and after the
insertion tool 22 is removed from the indwellingcatheter 20, is enhanced by coating theindwelling catheter 20 and portions of theinsertion tool 22 with a layer orcoating 109 of low friction material, such as parylene or a hydrophilic material, as shown inFIG. 3 . Thecoating 109 of the low friction material is applied to themain body 58, to cover itssidewall 60 on the exterior and interior, including thepassageway 56, theend piece 62 and theopenings 64 within theend piece 62. In other circumstances, anouter layer 109 of the low friction material may be integrally made a part of thesidewall 60, including thepassageway 56 and theopenings 64. The low friction material reduces the adherence of the blood clots within theopenings 64 and in thepassageway 56, and reduces the frictional force holding those blood clots in theopenings 64 and thepassageway 56. The reduced adherence or frictional holding force makes it easier to dislodge the clots, with natural fluid pressure from the bladder or when flushing the indwelling catheter with fluid through the insertion tool in the manner previously described, or in conjunction with the action of a clearing device described below. The low friction material on the interior surface of thepassageway 56 also reduces the resistance to the flow of urine and clots or other potential obstruction through thepassageway 56. The low friction material on the exterior surface of themain body 58 and on the exterior surface of theinsertion tool 22 facilitates insertion of the indwelling catheter in theurinary canal 36. - Another technique for obtaining increased resistance to blood clot obstructions of the
interior passageway 56 within thecatheter 20 is to increase the size of the inlet opening oropenings 64 through theend piece 62, or to orient the inlet opening 64 in a manner which inhibits clot accumulation, or to do both. Preferably, the cross-sectional size of the inlet opening or the cumulative cross-sectional sizes of all of the inlet openings should be substantially greater than the cross-sectional size of theinterior passageway 56, preferably at least two to four or more times greater.Indwelling catheters 20 a-20 d which employinlet openings 64 of increased size and direct orientation are shown inFIGS. 11-14 . The layer or coating 109 (FIG. 3 ) of the low friction material may also be used in conjunction with thecatheters 20 a-20 d shown inFIGS. 11-14 . - The
catheter 20 a shown inFIG. 11 has a single enlarged urine drainage inlet opening 64 a formed in theend piece 62 a. Theend piece 62 a retains the longitudinal half structure or portion of the roundeddistal end 38 of the end piece 62 (FIGS. 2 and 3 ), but the other longitudinal half portion is eliminated for a substantial longitudinal distance extending proximally from the most distal point of therounded end 38 to create the substantially enlarged inlet opening 64 a. The shape of theend piece 62 a and the inlet opening 64 a cause the distal end of theindwelling catheter 20 a to assume the shape or configuration of a whistle. For that reason, thecatheter 20 a is referred to as having awhistle tip 110. The substantially enlarged inlet opening 64 a into the interior passageway 56 (FIG. 3 ) from thebladder 32 makes it difficult for blood clots to accumulate within the inlet opening 64 a and to obstruct urine flow into and through thepassageway 56. The rounded distal end portion of thewhistle tip 110 facilitates the insertion of thecatheter 20 a into theurinary canal 36. - The indwelling
catheter 20 b shown inFIG. 12 has multiple urinedrainage inlet openings 64 b spaced at longitudinal and circumferential positions around theend piece 62 b. Each of theinlet openings 64 b communicates from the exterior of theend piece 62 b into theinterior passageway 56. Each of theinlet openings 64 b is approximately the same size as, or slightly smaller than, each of the pair ofinlet openings 64 in the roundeddistal end 38 of the end piece 62 (FIGS. 2 and 3 ), but the multiplicity of the inlet opening 64 b provides a cumulatively larger pathway for the urine to pass from the bladder into thepassageway 56 of thecatheter 20 b. Having a multiplicity ofinlet openings 64 b rather than asingle inlet opening 64 or a pair ofinlet openings 64 decreases the possibility that a blood clot will prevent urine from flowing into the interior passageway 56 (FIG. 3 ) from thebladder 32, and decreases the possibility of a single clot entering thecatheter 20 b and blocking the passageway 56 (FIG. 3 ). In the event that one or more of theinlet openings 64 b becomes obstructed with a blood clot, urine will flow into thepassageway 56 through one or more of the otherunobstructed openings 64 b. The multiple urinedrainage inlet openings 64 b in thecatheter 20 b cause it to be referred to as having amultiple opening tip 111. The roundeddistal end 38 of themultiple opening tip 111 facilitates the insertion of thecatheter 20 b into theurinary canal 36. - The indwelling
catheter 20 c shown inFIG. 13 has acouvelaire tip 112. Thecouvelaire tip 112 has a pair of relatively-large elongated or oval-shapedinlet openings 64 c positioned on diametrically opposite sides of theend piece 62 c. Theenlarged inlet openings 64 c are significantly larger than theinlet openings 62 typically found in a catheter (FIGS. 2 and 3 ). Preferably, the cross-sectional size of each of theinlet openings 64 c is significantly greater than the cross-sectional size of theinterior passageway 56. In addition, a transverse dimension of each inlet opening 64 c is preferably greater than one fourth of the circumferential distance around themain body 58 and the longitudinal dimension of each inlet opening 64 c is greater than the transverse dimension. The enlarged size makes it difficult for blood clots to accumulate within theinlet openings 64 c and to obstruct urine flow into and through the interior passageway 56 (FIG. 3 ). The roundeddistal end 38 of thecouvelaire tip 112 facilitates the insertion of thecatheter 20 c into theurinary canal 36. - The indwelling
catheter 20 d shown inFIG. 14 has abeveled tip 114. Theend piece 62 d includes a somewhat flatbeveled surface 116 that extends at an acute angle more transversely relative to the axis of the catheter from thedistal end 38 of theend piece 62 d than longitudinally. A single urinedrainage inlet opening 64 d is formed through thebeveled surface 116. Because of the transverse angle of thebeveled surface 116 relative to the axis of thecatheter 20, the flow passageway through the inlet opening 64 d more directly aligns with and enters the interior passageway 56 (FIG. 3 ). Thesingle inlet opening 64 d can be made of a size larger than the cross-sectional size of thepassageway 56. The more-directly entering flow passageway through the inlet opening 64 d avoids the right angle turn associated with theopenings 62 in the end piece 64 (FIGS. 2 and 3 ). The more-directly entering flow passageway through the inlet opening 64 d provides less of an obstruction or restriction for the blood clots to accumulate and to obstruct thepassageway 56. Theend piece 62 d retains a roundeddistal end 38 which facilitates insertion of thecatheter 20 d intourinary canal 36. Thebeveled surface 116 also facilitates insertion of thecatheter 20 d into the urinary canal. - Obstructions from blood clots and other urinary tract matter can also be avoided by incorporating a
clearing device 120 within the indwellingcatheter 20 e, as shown inFIG. 15 . Theclearing device 120 is located within theinterior passageway 56 of thecatheter 20 e and includes an obstruction clearing contact element (e.g., brush structure 122) which is movable longitudinally along theinterior passageway 56. The obstruction clearing contact element dislodges the blood clots or other obstructions within thepassageway 56, or breaks the blood clots or obstructions into smaller pieces, or breaks open the accumulation of clots or obstructions in theopenings 64, as a result of movement of the clot clearing contact element within thepassageway 56, as shown inFIG. 16 . Dislodging or breaking up the clots and obstructions opens thepassageway 56 to the flow of urine and carries the obstructions out of the urinary tract with the flow of urine. - One form of the contact element of the
clearing device 120 utilizes abrush structure 122 formed by a plurality of bristles held together to form thebrush structure 122. Under normal use conditions, thebrush structure 122 is retained in a stowed position at an internaldistal end 124 of thepassageway 56 within theend piece 62, spaced slightly distally from theinlet openings 64, as shown inFIG. 15 . Thebrush structure 122 is held in the stowed position by bias force from areturn spring 126 which extends between thebrush structure 122 and the internaldistal end 124 of thepassageway 56. In its stowed position, thebrush structure 122 does not interfere with the flow of urine through theinlet openings 64 and theinterior passageway 56. - A thread-
like tether 128 is attached to thebrush structure 122 and thespring 126, and thetether 128 extends through thepassageway 56 of thecatheter 20 e on the opposite side of thebrush structure 122 from thereturn spring 126. When thecatheter 20 e is attached to the insertion tool 22 (FIG. 1 ), thetether 128 extends through thepassageway 56 and theinterior channel 88 of the insertion tool 22 (FIG. 10 ) and out of the handle 82 (FIG. 1 ). Once the indwellingcatheter 20 e has been inserted into theurinary canal 36 in its final position within the bladder and the prostatic urethra (FIG. 7 ), theinsertion tool 22 is disconnected from the indwellingcatheter 20 e and theinsertion tool 22 is removed in the manner previously described. Thetether 128 remains in position within theurinary canal 36 as theinsertion tool 22 is removed, as a result of thetether 128 moving through theinterior channel 88 of the insertion tool. The proximal end of thetether 128 remains exterior of theurinary canal 36. - When it is determined that the urine flow path through the
passageway 56 is obstructed by blood clots, thebrush structure 122 is moved out of the stowed position (FIG. 15 ) and is moved longitudinally proximally along theinterior passageway 56 by pulling proximal end of thetether 128 at the exterior of theurinary canal 36, as shown inFIG. 16 . The resiliency of thereturn spring 126 permits proximal longitudinal movement. As thebrush structure 122 moves along thepassageway 56, the blood clots or obstructions are contacted by thebrush structure 122. The longitudinal movement of the brush structure dislodges and shears the clots out of theinlet openings 64 and thepassageway 56. Deflected bristles of thebrush structure 122 within theinterior passageway 56 spring outwardly through theinlet openings 64 to push the clots or obstructions out of those inlet openings. The bristles of thebrush structure 122 also shear or break the clots or obstructions within the inlet openings and thepassageway 56 into smaller pieces. The dislodged, broken and smaller clots or obstructions flow with the urine through the openedpassageway 56 and into theurinary canal 36, or the movement of thebrush structure 122 pushes the clots or obstructions through thepassageway 56 out of thecatheter 20 e. The clots or obstructions thereafter pass through the remaining portion of theurinary canal 36 and out of the body by the flow of urine. Thetether 128 constitutes one form of an activation device for operating theobstruction clearing device 120. - After the
brush structure 122 has cleared the clots from theinlet opening 64 and thepassageway 56, thetether 128 is released and thereturn spring 126 pulls thebrush structure 122 from the position shown inFIG. 16 back into the stowed position at the internaldistal end 124 of thepassageway 56 shown inFIG. 15 . Thereafter, urine may again flow through thepassageway 56 in the normal matter. Should the inlet opening 64 or thepassageway 56 again become obstructed, thebrush structure 122 can again be moved longitudinally by pulling on thetether 128 to again clear the urine flow path through theinlet openings 64 and thepassageway 56. Theclearing device 120 can be used as many times as needed in this manner to keep thecatheter 20 e open to the flow of urine. - An alternative form of the
clearing device 120 provides for a one-time use to clear the urine flow passageway. In this circumstance, thereturn spring 126 is omitted. Thebrush structure 122 is retained in the stowed position (FIG. 15 ) by frictional forces between the bristles and the inside surface of thepassageway 56 at the internaldistal end 124. If the urine flow through thepassageway 56 becomes obstructed, thetether 128 is pulled and thebrush structure 122 is moved from the stowed position longitudinally through the passageway 56 (FIG. 16 ), thereby clearing the passageway of clots or obstructions. Continuing to pull thetether 128 removes thebrush structure 122 from theinterior passageway 56 and into theurinary canal 36. Theclearing device 120 is then pulled completely out of theurinary canal 36. - In this way the obstruction is removed at the same time that the
brush structure 122 is removed from within the indwellingcatheter 20 e. While theclearing device 120 can only be used once in this manner, a single use may prove satisfactory for those TUMT, heat treatment and other patients for whom blood clots and other obstructions are not expected to be a significant issue. Also, the use of the single-useclearing indwelling catheter 20 e may be prescribed if the physician knows or prefers to replace theindwelling catheter 20 e on a periodic basis during healing. - The
clearing device 120 can be used while theinsertion tool 22 remains connected to theindwelling catheter 20 e for flushing thecatheter 20. Thetether 128 extends through theinterior channel 88 in theinsertion tool 22 and therefore does not interfere with the flow of flushing fluid through theinterior channel 88 and into theinterior passageway 56. Clearing the blood clots or obstructions by use of theclearing device 120 in combination with flushing or in alternation with flushing, may be reserved for those situations where flushing by itself is insufficient to eliminate the obstructions. Using theclearing device 120 can also enhance the effect of the flushing, by loosening and breaking the clots or obstructions prior to flushing. In this manner, the amount and extent of flushing may be reduced, which can be important in minimizing the discomfort associated with forcing additional flushing fluid into an already-filled bladder. - Forcing the flushing fluid into the
interior channel 88 andinterior passageway 56 may also move thebrush structure 122 back to the stowed position. In this circumstance, thereturn spring 126 is not needed to obtain multiple uses of theclearing device 120. Forcing the flushing fluid into theinterior channel 88 andinterior passageway 56 may also help to move thebrush structure 122 back to the stowed position, thereby assisting thereturn spring 126. - In those catheters having
inlet openings 64 spaced slightly proximally of the distal most end 38 (e.g.FIGS. 3, 12 , 13), as represented inFIG. 15 , the stowed position of theclearing device 120 is slightly distal of the mostdistal openings 64 within theinterior passageway 56. In those catheters which have inlet openings that extend to or through the distal most end 38 (e.g.FIGS. 11 and 14 ), theclearing device 120 may take a different form from thebrush structure 122 or a part of the urine flow may normally pass through thebrush structure 122. The different form of theclearing device 120 may permit it to move out of the path of the normal urine flow through theinterior passageway 56 yet move across theinlet openings 64 and along theinterior passageway 56 in such a way to clear obstructions within the inlet openings. This may be accomplished by rotating and longitudinally moving theclearing device 120 within theinterior passageway 56, rather than solely moving theclearing device 120 longitudinally within theinterior passageway 56. If theinlet openings 64 are sufficiently large, the exposedbrush structure 122 may not substantially interfere with normal urine flow, because the size of theinlet opening 64 is so large that the presence of thebrush structure 122 at a portion of theinlet openings 64 is not significant. Any clots which might form on thebrush structure 120 to itself are broken as the brush structure moves into theinterior passageway 56, while still breaking, sharing and dislodging other obstructions present in the interior passageway. - Although the enlarged urinary inlet opening configurations of 64 a-64 d and the
clearing device 120 have been shown in connection with a partial-length indwelling catheter, they are also applicable for use in full-length catheters. Use with a full-length catheter occurs in the same manner as occurs while theinsertion tool 22 remains connected to the partial length catheter. - In the manner described, the partial-length catheter allows voluntary natural use of the external
urinary sphincter muscle 34 to start and stop urine flow. The location of the indwelling catheter within theprostate gland 30 bypasses most of the urine flow from contact with the tissue of theprostate gland 30 which has been affected by the surgical procedure, thereby preventing or lessening pain and irritation. Any blood which may accumulate within the interior passageway of the indwelling catheter, and possibly cause obstructions due to clots, is flushed and cleared from the interior of the indwelling catheter prior to removal of theinsertion tool 22. The separation of theinsertion tool 22 from the indwellingcatheter 20 may be delayed until the risks of obstructions from blood clots and the like has passed. - The indwelling catheter also assures a passageway for urine to flow through a
prostate gland 30 that is diseased and swollen from BPH or other diseases. The catheter reliably remains in position for use due to the anchoring effects of theinflated balloon 40 and the coiledsection 54, thereby lessening the risk of further surgical procedures to reposition and remove an inadvertently displaced catheter. Obstructions blocking the urine flow into and through the catheter, such as blood clots, are reduced or eliminated by the low friction coating and the various configurations of theinlet openings 64 at the distal end of the catheter. If theinterior passageway 56 does become obstructed, the blood clot or otherobstruction clearing device 120 is selectively movable within thepassageway 56 to eliminate the obstruction without having to resort to a surgical procedure for replacing thecatheter 20. - Presently preferred embodiments of the invention and many of its improvements have been described above with a degree of particularity. The description is of preferred examples for implementing the invention, and is not necessarily intended to limit the scope of the invention. The scope of the invention is defined by the following claims.
Claims (62)
1. A catheter for insertion in a urinary tract to drain urine from a bladder to a location adjacent to an orifice in an external urinary sphincter muscle which controls urine flow into a urinary canal of the urinary tract, comprising:
a main body having a distal end, a proximal end and a length sufficient to position the distal end within the bladder and to position the proximal end adjacent to and distal of the orifice in the external urinary sphincter muscle, the main body defining an urine drainage interior passageway extending from the distal end to the proximal end, the interior passageway having a cross-sectional size;
a distal anchor attached to the distal end of the main body and expandable within the bladder to restrain the main body against proximal movement within the urinary tract from a use position in which the distal end of the main body is located in the bladder and the proximal end of the main body is located adjacent to and distal of the orifice in the external urinary sphincter muscle;
a proximal anchor attached to the proximal end of the main body to restrain the main body against distal movement in the urinary tract from the use position; and
at least one urine inlet opening extending through the distal end of the main body and into the interior passageway, each inlet opening having a cross sectional size, the cumulative cross-sectional size of all inlet openings in the distal end being greater than the cross-sectional size of the interior passageway to facilitate passing urine and blood clots from the bladder into the interior passageway while reducing an accumulation of blood clots within the inlet opening and the interior passageway.
2. A catheter as defined in claim 1 , wherein:
the distal end includes a rounded tip;
a single inlet opening extends through the distal end of the main body;
the single inlet opening has a predetermined configuration; and
the predetermined configuration of the inlet opening is defined by the absence of a longitudinal half portion of the rounded tip and the distal end adjacent to the rounded tip, the longitudinal half portion defined substantially by a longitudinal bisection of the rounded tip and the portion of the distal end adjoining the rounded tip.
3. A catheter as defined in claim 2 , wherein:
the single inlet opening and a remaining longitudinal half portion of the rounded tip and the distal end establish a whistle-tip shape of the distal end of the main body.
4. A catheter as defined in claim 1 , wherein:
the distal end includes a rounded tip;
a plurality of inlet openings extend through the distal end of the main body; and
each of the inlet openings is longitudinally spaced from an adjacent inlet opening along the portion of the distal end adjacent to the rounded tip.
5. A catheter as defined in claim 4 , wherein:
each of the inlet openings is also circumferentially spaced from an adjacent inlet opening along the portion of the distal end adjacent to the rounded tip.
6. A catheter as defined in claim 1 , wherein:
the distal end includes a rounded tip;
two inlet openings extend through the distal end of the main body; and
the two inlet openings are positioned radially opposite one another on the distal portion of the main body adjacent to the rounded tip, each of the two inlet openings has a cross-sectional size, and the cross-sectional size of each of the two inlet openings is substantially greater than the cross-sectional size of the interior passageway.
7. A catheter as defined in claim 6 , wherein:
each of the two inlet openings has a circumferential dimension greater than one-fourth of the circumferential distance around the main body.
8. A catheter as defined in claim 6 , wherein:
each of the two inlet openings is elongated with a longer dimension of each elongated opening extending longitudinally along the distal end.
9. A catheter as defined in claim 6 , wherein:
each of the two inlet openings defines a couvelaire tip configuration of the distal end of the main body.
10. A catheter as defined in claim 1 , wherein:
the distal end includes a beveled surface which extends substantially transversely at an acute angle relative to a longitudinal axis through the distal end;
a single inlet opening extends through the distal end of the main body; and
the single inlet opening extends through the beveled surface substantially directly into the interior passageway of the main body.
11. A catheter as defined in claim 1 , further comprising:
a low friction coating extending over the distal end, within each inlet opening, and along the interior passageway.
12. A catheter as defined in claim 1 , further comprising:
a clearing device positioned within the interior passageway and including a contact element movable within the interior passageway past each inlet opening to contact and disintegrate and facilitate movement of blood clots and obstructions within each inlet opening and the interior passageway with the flow of urine through the interior passageway.
13. A catheter as defined in claim 12 , wherein:
the contact element is normally positioned within the interior passageway in a stowed position between each inlet opening and a distal end of the interior passageway; and
the contact element is movable from the stowed position to a position proximal of each inlet opening in the interior passageway through the main body.
14. A catheter as defined in claim 13 , further comprising:
an activation device connected to the contact element and extending through the urinary canal to a position outside an exterior opening of the urinary canal; and wherein:
the contact element is selectively moved by manipulation of the activation device at the position outside the exterior opening of the urinary canal.
15. A catheter as defined in claim 14 , further comprising in combination:
an insertion tool for inserting the catheter into the urinary tract to the use position, the insertion tool having a distal end for connecting with the proximal end of the main body and a proximal end that extends to a position outside the exterior opening of the urinary canal, the insertion tool having an interior channel extending from its distal end to its proximal end, the interior channel communicating with the interior passageway in the main body when the distal end of the insertion tool is connected to the proximal end of the main body; and wherein:
the activation device extends through the interior channel of the insertion tool when the insertion tool is connected to the main body.
16. A catheter as defined in claim 1 , wherein:
the distal anchor comprises a balloon attached to the distal end of the main body, the balloon is expandable in size when inflated within the bladder to maintain the distal end of the main body in the bladder and to restrain the main body against proximal movement from the use position; and further comprising:
an inflation tube having a distal end, a proximal end and a length extending between the distal and proximal ends, the distal end of the inflation tube connected to the main body, the length of the inflation tube sufficient to extend from the main body through the orifice of the external urinary sphincter muscle and the urinary canal to a position outside of an exterior opening of the urinary canal, the inflation tube and the main body establishing an inflation passageway extending from the proximal end of the inflation tube to the balloon through which to deliver fluid to inflate the balloon.
17. A catheter as defined in claim 16 , wherein:
the proximal anchor comprises a coiled section of the inflation tube located at a position adjacent to and proximal of the sphincter muscle when the main body is in the use position, the coiled section interacting with the external urinary sphincter muscle when constricted to restrain the main body against distal movement from the use position
18. A method of making an urinary catheter more resistant to obstructions from blood clots in a urine flowpath from a bladder through an interior passageway of the catheter, comprising:
locating at least one urine inlet opening within an end piece of the catheter to conduct urine from the bladder into the interior passageway when the end piece is located in the bladder; and
forming each inlet opening with a predetermined configuration and a cross-sectional size to facilitate passing urine and blood clots from the bladder into the interior passageway while reducing an accumulation of blood clots within the inlet opening and the interior passageway, the cumulative cross-sectional size of all inlet openings being greater than the cross-sectional size of the interior passageway.
19. A method as defined in claim 18 , further comprising:
forming a single inlet opening in a configuration of a whistle tip.
20. A method as defined in claim 18 , further comprising:
forming a single inlet opening in a configuration in which a substantially longitudinally bisectioned portion of the end piece is absent.
21. A method as defined in claim 18 , further comprising:
forming a plurality of separate inlet openings each of which is longitudinally spaced from an adjacent separate opening along the end piece.
22. A method as defined in claim 18 , further comprising:
forming a plurality of separate inlet openings each of which is circumferentially spaced from an adjacent separate opening around the end piece.
23. A method as defined in claim 18 , further comprising:
forming a plurality of separate openings each of which is longitudinally and circumferentially spaced from an adjoining separate opening on the end piece.
24. A method as defined in claim 18 , further comprising:
forming two separate openings at radially opposite positions on the end piece as a couvelaire tip.
25. A method as defined in claim 18 , further comprising:
forming two separate openings at radially opposite positions on the end piece; and
forming each of the two separate openings with a greater longitudinal dimension than a circumferential dimension.
26. A method as defined in claim 18 , further comprising:
creating a beveled portion on the end piece which extends at a more transverse rather than longitudinal angle relative to a longitudinal axis through the end piece;
forming a single inlet opening through the end piece; and
extending the single inlet opening through the beveled surface substantially directly into the interior passageway of the main body.
27. A method as defined in claim 18 , further comprising:
coating the end piece, each inlet opening and the interior passageway with a low friction coating.
28. A method as defined in claim 18 , further comprising:
positioning a contact element within the interior passageway for movement within the interior passageway and relative to each inlet opening and the interior passageway; and
moving the contact element within the interior passageway to contact and disintegrate and facilitate movement of blood clots and obstructions within at least one inlet opening and the interior passageway with the flow of urine through the interior passageway.
29. A catheter for insertion in an urinary tract to drain urine from a bladder through a urinary canal and out of an exterior opening of the urinary canal, comprising:
a main body having a distal end and a length sufficient to position the distal end within the bladder, the main body defining an urine drainage interior passageway;
an urine inlet opening extending through the distal end into the interior passageway to pass urine from the bladder into the interior passageway; and
a clearing device comprising a contact element moveably positioned within the interior passageway for movement past the inlet opening and along the interior passageway to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway with the flow of urine through the interior passageway.
30. A catheter as defined in claim 29 , further comprising:
an activation device connected to the contact element and extending through the interior passageway and extendable from the main body through the urinary canal to a position outside of the exterior opening of the urinary canal, the activation device moving the contact element by manipulation of the activation device at the position outside the exterior opening of the urinary canal.
31. A catheter as defined in claim 30 , wherein:
the activation device comprises a tether connected to the contact element to move the contact element past the inlet opening and along the interior passageway upon pulling the tether at the position outside the exterior opening of the urinary canal.
32. A catheter as defined in claim 31 , wherein:
the contact element is retained within the interior passageway for removal and transportation through the interior passageway and out of the main body by pulling the tether after moving the contact element past the inlet opening.
33. A catheter as defined in claim 30 , further comprising:
a return element connected between the contact element and the main body to bias the contact element into an initial position from which the contact element commences movement; and
the return element moving the contact element back to approximately the initial position after the contact element has been moved past the inlet opening and along the interior passageway.
34. A catheter as defined in claim 33 , wherein:
the return element comprises a spring.
35. A catheter as defined in claim 33 , wherein:
the activation device comprises a tether connected to the contact element to move the contact element past the inlet opening and along the interior passageway upon pulling the tether at the position outside the exterior opening of the urinary canal.
36. A catheter as defined in claim 30 , wherein:
the contact element is positioned within the interior passageway for removal out of the main body after the contact element has been moved past the inlet opening and along the interior passageway.
37. A catheter as defined in claim 36 , wherein:
the activation device comprises a tether connected to the contact element to move the contact element past the inlet opening and along the interior passageway and remove the contact element out of the main body upon pulling the tether at the position outside the exterior opening of the urinary tract.
38. A catheter as defined in claim 29 , wherein:
the contact element comprises a brush structure.
39. A catheter as defined in claim 38 , wherein:
the brush structure includes a plurality of bristles.
40. A catheter as defined in claim 39 , wherein:
the brush structure is maintained in the interior passageway by friction between the bristles and the interior passageway until the contact member is moved.
41. A catheter as defined in claim 29 , wherein:
the contact element occupies an initial position within the interior passageway from which the contact element commences movement; and
the contact member is returned to the starting position by the application of fluid pressure through the interior passageway of the main body after the contact element has been moved past the inlet opening and along the interior passageway.
42. A catheter as defined in claim 29 wherein the catheter is of the partial-length indwelling type used to drain urine from the bladder to a location adjacent to an orifice in an external urinary sphincter muscle which controls urine flow into a urinary canal of the urinary tract, wherein:
the main body has a distal end, a proximal end and a length sufficient to position the distal end within the bladder and to position the proximal end adjacent to and distal of the orifice in the external urinary sphincter muscle when the catheter is in a use position.
43. A catheter as defined in claim 42 , further comprising:
an activation device connected to the contact element and extending through the interior passageway and extendable from the main body through the orifice of the external urinary sphincter muscle and through the urinary canal to a position outside of the exterior opening of the urinary canal, the activation device moving the contact element by manipulation of the activation device at the position outside the exterior opening of the urinary canal.
44. A catheter as defined in claim 43 , further comprising in combination:
an insertion tool for inserting the catheter into the urinary tract to the use position, the insertion tool having a distal end for connecting with the proximal end of the main body and a proximal end that extends to a position outside the exterior opening of the urinary canal, the insertion tool having an interior channel extending from its distal end to its proximal end, the interior channel communicating with the interior passageway in the main body when the distal end of the insertion tool is connected to the proximal end of the main body; and wherein:
the activation device extends through the interior channel of the insertion tool when the insertion tool is connected to the main body.
45. A catheter as defined in claim 42 , further comprising:
a balloon attached to the distal end of the main body, the balloon is expandable in size when inflated within the bladder to maintain the distal end of the main body in the bladder and to restrain the main body against proximal movement from the use position; and
an inflation tube having a distal end, a proximal end and a length extending between the distal and proximal ends, the distal end of the inflation tube connected to the main body, the length of the inflation tube sufficient to extend from the main body through the orifice of the external urinary sphincter muscle and the urinary canal to a position outside of an exterior opening of the urinary canal, the inflation tube and the main body establishing an inflation passageway extending from the proximal end of the inflation tube to the balloon through which to deliver fluid to inflate the balloon.
46. A catheter as defined in claim 45 , further comprising:
a proximal anchor connected to the proximal end of the main body and located at a position adjacent to and proximal of the external urinary sphincter muscle when the main body is in the use position, the proximal anchor interacting with the external urinary sphincter muscle when constricted to restrain the main body against distal movement from the use position.
47. A catheter as defined in claim 46 , wherein:
the proximal anchor comprises a coiled section of the inflation tube formed at a position along the inflation tube to be adjacent to and proximal of the sphincter muscle when the main body is located in the use position.
48. A catheter as defined in claim 29 , wherein:
the contact element is retained within the interior passageway in a stowed position at a distal end of the interior passageway;
the contact element when in the stowed position is substantially out of a urine drainage flow path through the inlet opening and the interior passageway; and
the contact element is returned to the stowed position after the contact element has been moved past the inlet opening and along the interior passageway.
49. A method of making an urinary catheter more resistant to obstructions from blood clots in a urine flowpath from a bladder through urinary tract, the catheter having a main body with an interior passageway for draining the urine through the catheter and an urine inlet opening formed through the main body and into the interior passageway at a distal end, comprising:
moving a clot clearing contact element positioned within the interior passageway past the inlet opening and along a portion of the interior passageway to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway with the flow of urine through the interior passageway.
50. A method as defined in claim 49 , further comprising:
stowing the contact element in a stowed position substantially out of the urine flow path through the inlet opening and into the interior passageway before moving the contact element.
51. A method as defined in claim 49 , further comprising:
positioning the contact element in a stowed position located at a distal end of the interior passageway before moving the contact element to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
52. A method as defined in claim 49 , further comprising:
moving the contact element by transferring force to the contact element through an urinary canal of the urinary tract from a position outside of an exterior opening of the urinary canal to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
53. A method as defined in claim 52 , further comprising:
extending a tether connected to the contact element from the contact element through the interior passageway and the urinary canal to the exterior opening of the urinary canal; and
pulling the tether to transfer force to move the contact element to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
54. A method as defined in claim 53 , further comprising:
removing the contact element from the interior passageway by continuing to pull the tether after the contact element has been moved to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
55. A method as defined in claim 50 , further comprising:
returning the contact element to the stowed position after having moved the contact element to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
56. A method as defined in claim 49 , further comprising:
using a brush structure as the contact element to contact and disintegrate and facilitate movement of blood clots and obstructions within the inlet opening and the interior passageway.
57. A method as defined in claim 49 wherein the catheter is of the partial-length indwelling type used to drain urine from the bladder to a location adjacent to an orifice in an external urinary sphincter muscle which controls urine flow into a urinary canal of the urinary tract, further comprising:
positioning the distal end of the main body within the bladder when the catheter is in a use position; and
positioning a proximal end of the main body adjacent to and distal of the external urinary sphincter muscle when the catheter is in the use position.
58. A method as defined in claim 57 , further comprising:
moving the contact element by transferring force to the contact element through the urinary canal and the orifice of the external urinary sphincter muscle from the position outside of the exterior opening of the urinary canal.
59. A method as defined in claim 57 , further comprising:
connecting the proximal end of the main body to an insertion tool;
inserting the catheter through the urinary canal into the use position by movement imparted through the insertion tool; and
extending an activation device through an interior channel of the insertion tool to transfer force to the contact element through the urinary canal and the orifice of the external urinary sphincter muscle from the position outside of the exterior opening of the urinary canal.
60. A method as defined in claim 57 , wherein the catheter is further of the type comprising a balloon attached to the distal end of the main body and an inflation tube communicating with an interior of the balloon and extending from the main body through the urinary canal to the position outside of the exterior opening of the urinary canal when the catheter is in the use position, the method further comprising:
delivering fluid through the inflation passageway to inflate the balloon within the bladder and restrain the main body against proximal movement from the use position.
61. A method as defined in claim 60 , further comprising:
anchoring the catheter within the urinary canal adjacent to and proximal of the external urinary sphincter muscle to restrain the main body against distal movement from the use position.
62. A method as defined in claim 60 , further comprising:
locating a coiled section of the inflation tube adjacent to and proximal of the external urinary sphincter muscle to restrain the main body against distal movement from the use position.
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/921,356 US20050080399A1 (en) | 2003-09-17 | 2004-08-18 | Urinary catheter and method with increased resistance to obstructions |
CN2004800268804A CN1852747B (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with inflation tube anchor and for preventing and clearing obstruction |
ES04775424T ES2346316T3 (en) | 2003-09-17 | 2004-09-15 | PERMANENT PROSTATIC CATHETER OF PARTIAL LENGTH WITH INFLATION TUBE IN SPIRAL. |
RU2006112400/14A RU2372111C2 (en) | 2003-09-17 | 2004-09-15 | Permanent prostatic catheter with anchor inflatable tube |
AT04775424T ATE468145T1 (en) | 2003-09-17 | 2004-09-15 | SHORTENED INDATED PROSTATE CATHETER WITH COIL-SHAPED INFLATION TUBE |
KR1020067005262A KR20060073625A (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with inflation tube anchor and obstruction resistance and clearing |
JP2006526853A JP4427546B2 (en) | 2003-09-17 | 2004-09-15 | Partial length indwelling prostate catheter with inflation tube anchor, occlusion resistance and removal function |
AU2004271882A AU2004271882B2 (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with inflation tube anchor and obstruction resistance and clearing |
DE602004027282T DE602004027282D1 (en) | 2003-09-17 | 2004-09-15 | BRUSHED PROSTATE DWELLING CATHETER WITH ROLLING TUBE |
EP04775424A EP1680174B1 (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with coiled inflation tube |
PCT/SE2004/001320 WO2005025665A1 (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with inflation tube anchor and obstruction resistance and clearing |
CA002536529A CA2536529A1 (en) | 2003-09-17 | 2004-09-15 | Partial-length, indwelling prostatic catheter with inflation tube anchor and obstruction resistance and clearing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/665,742 US7766899B2 (en) | 2003-09-17 | 2003-09-17 | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
US10/921,356 US20050080399A1 (en) | 2003-09-17 | 2004-08-18 | Urinary catheter and method with increased resistance to obstructions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/665,742 Continuation-In-Part US7766899B2 (en) | 2003-09-17 | 2003-09-17 | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050080399A1 true US20050080399A1 (en) | 2005-04-14 |
Family
ID=34274686
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/665,742 Expired - Fee Related US7766899B2 (en) | 2003-09-17 | 2003-09-17 | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
US10/921,356 Abandoned US20050080399A1 (en) | 2003-09-17 | 2004-08-18 | Urinary catheter and method with increased resistance to obstructions |
US12/818,572 Active 2024-10-16 US8518016B2 (en) | 2003-09-17 | 2010-06-18 | Method of using a partial-length, indwelling prostatic catheter having a coiled inflation tube as an anchor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/665,742 Expired - Fee Related US7766899B2 (en) | 2003-09-17 | 2003-09-17 | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/818,572 Active 2024-10-16 US8518016B2 (en) | 2003-09-17 | 2010-06-18 | Method of using a partial-length, indwelling prostatic catheter having a coiled inflation tube as an anchor |
Country Status (5)
Country | Link |
---|---|
US (3) | US7766899B2 (en) |
CN (1) | CN1852747B (en) |
AT (1) | ATE468145T1 (en) |
DE (1) | DE602004027282D1 (en) |
ES (1) | ES2346316T3 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050059929A1 (en) * | 2003-09-17 | 2005-03-17 | Magnus Bolmsjo | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
US20050288639A1 (en) * | 2004-06-25 | 2005-12-29 | Hibner Michael C | Instrument used in treatment of the urinary incontinence in women |
US20060015190A1 (en) * | 2002-04-16 | 2006-01-19 | Robertson David W | Ureteral stent with end-effector and related methods |
US20060129136A1 (en) * | 2004-12-09 | 2006-06-15 | Meacham George B K | Catheter |
US20090187143A1 (en) * | 2008-01-18 | 2009-07-23 | Ev3 Inc. | Angled tip catheter |
US20100016839A1 (en) * | 2006-10-25 | 2010-01-21 | Sobhy Shehata | Apparatus and method for the controlled hydrodistention of the urinary bladder |
US20110054448A1 (en) * | 2009-08-28 | 2011-03-03 | Navilyst Medical, Inc. | Medical device containing catheter anchoring feature |
US20120158025A1 (en) * | 2010-12-15 | 2012-06-21 | Christopher Anderson | Anastomosis device and related methods |
US8328792B2 (en) | 2005-10-27 | 2012-12-11 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US20130123622A1 (en) * | 2010-06-11 | 2013-05-16 | Universitätsmedizin Der Johannes Gutenberg Universität Mainz | Balloon catheter system for draining fluids from hollow organs, body cavities or cysts and/or for supplying medication |
WO2014116718A1 (en) * | 2013-01-22 | 2014-07-31 | Percutaneous Systems, Inc. | Ureteral stent and method and system for its deployment |
US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
US20150088090A1 (en) * | 2012-02-21 | 2015-03-26 | Hospi Corporation | Method and apparatus for a clog resistant orifice |
US8998882B2 (en) | 2013-03-13 | 2015-04-07 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US9033149B2 (en) | 2010-03-04 | 2015-05-19 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and a foil outer layer and method of making and using the same |
US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US9821139B2 (en) | 2009-08-13 | 2017-11-21 | C. R. Bard, Inc. | Catheter having internal hydrating fluid storage and/or catheter package using the same and method of making and/or using the same |
US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
US10149961B2 (en) | 2009-07-29 | 2018-12-11 | C. R. Bard, Inc. | Catheter having improved drainage and/or a retractable sleeve and method of using the same |
US10518069B2 (en) | 2016-10-28 | 2019-12-31 | Integra LifeSciences Switzerland Sarl | Implantable valve assembly with extended lifespan |
US10857324B2 (en) | 2014-08-26 | 2020-12-08 | C. R. Bard, Inc. | Urinary catheter |
US10912917B2 (en) | 2009-12-23 | 2021-02-09 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and method of making and using the same |
KR20220080068A (en) * | 2020-03-05 | 2022-06-14 | 울산대학교 산학협력단 | Foley catheter assembly |
US11547599B2 (en) | 2017-09-19 | 2023-01-10 | C. R. Bard, Inc. | Urinary catheter bridging device, systems and methods thereof |
US20230010429A1 (en) * | 2019-09-06 | 2023-01-12 | Blue Halo BioMedical, LLC | Coil catheter, method of use, and method of manufacture |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7662145B2 (en) * | 2003-09-17 | 2010-02-16 | Prostalund Operations Ab | Partial-length indwelling urinary catheter and method permitting selective urine discharge |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US8419710B2 (en) * | 2006-12-06 | 2013-04-16 | Medtronic, Inc. | Methods for infusing fluids via an implantable infusion system |
WO2011156714A2 (en) | 2010-06-10 | 2011-12-15 | Chambers Dr Jeffrey W | Systems and methods for preventing formation of blood clots in the left atrium |
US20120203210A1 (en) * | 2011-02-07 | 2012-08-09 | Schanz Richard W | Urinary catheter and method |
TWI438476B (en) | 2012-01-12 | 2014-05-21 | Largan Precision Co Ltd | Image capturing system |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
WO2014018386A1 (en) | 2012-07-23 | 2014-01-30 | University Of Utah Research Foundation | Indwelling urinary catheter |
EP2885043A4 (en) * | 2012-08-17 | 2016-07-13 | Chris Salvino | Improved nasogastric tube |
WO2014203259A1 (en) * | 2013-06-20 | 2014-12-24 | Hadasit Medical Research Services And Development Ltd. | Devices and methods for percutaneous endoscopic gastrostomy and other ostomy procedures |
US10300244B2 (en) | 2013-07-22 | 2019-05-28 | Renalsense Ltd. | Unravelable catheter |
CN104415449B (en) * | 2013-08-21 | 2019-12-10 | 复旦大学附属肿瘤医院 | Bladder irrigation anti-blocking catheter |
US9155868B2 (en) * | 2013-08-30 | 2015-10-13 | Medtronic, Inc. | Delivery catheter apparatus and methods |
JP6747644B2 (en) * | 2013-12-30 | 2020-08-26 | メディ−テイト リミテッド | Incision implant for urethral prostate |
US10610677B2 (en) | 2014-05-19 | 2020-04-07 | Celeste V. Bonham | Urological system that includes connector with integrated non-return check valve for extension tubing and urology collection systems |
JP2016067697A (en) * | 2014-09-30 | 2016-05-09 | テルモ株式会社 | Urethral stenosis treatment device and urethral stenosis treatment method |
US9744015B2 (en) | 2014-11-17 | 2017-08-29 | Coloplast A/S | Urethra cuff including tube |
WO2016103268A1 (en) | 2014-12-23 | 2016-06-30 | Fidmi Medical Ltd. | Devices and methods for percutaneous endoscopic gastronomy and other ostomy procedures |
WO2017109788A1 (en) | 2015-12-23 | 2017-06-29 | Fidmi Medical Ltd. | Devices and methods for ports to living tissue and/or lumens and related procedures |
US10702304B2 (en) | 2014-12-23 | 2020-07-07 | Fidmi Medical Ltd. | Devices and methods for ports to living tissue and/or lumens and related procedures |
CN104436335A (en) * | 2014-12-24 | 2015-03-25 | 陈高科 | Leakage urine drainage type bladder urinary catheterization device |
CN104826215B (en) * | 2015-05-25 | 2018-09-04 | 陈劲松 | One-pass molding cluster catheter and its production method |
CN105268088A (en) * | 2015-11-30 | 2016-01-27 | 杨春光 | Novel cerebral hematoma drainage tube |
US11052234B2 (en) | 2017-02-15 | 2021-07-06 | Celeste V. Bonham | Connector with integrated non-return check valve for extension tubing and urology collection systems |
SG11201909414PA (en) | 2017-08-16 | 2019-11-28 | Intervaal Pte Ltd | Catheter device and method of using the same |
US10010392B1 (en) * | 2017-09-06 | 2018-07-03 | Stanislaw L Zukowski | Indwelling valve actuated urinary catheter |
WO2019126718A1 (en) | 2017-12-23 | 2019-06-27 | Neotract, Inc. | Expandable tissue engagement apparatus and method |
CN108066883A (en) * | 2017-12-28 | 2018-05-25 | 南京医科大学第附属医院 | A kind of catheter |
US20210038861A1 (en) * | 2018-02-02 | 2021-02-11 | Microbot Medical Ltd. | Self-cleaning catheter systems with self-monitoring capabilities |
CN108325051B (en) * | 2018-03-28 | 2023-11-07 | 崔建忠 | Multifunctional intracerebral hematoma drainage tube containing multi-son tube |
CN109528319A (en) * | 2018-12-29 | 2019-03-29 | 天津美电医疗科技有限公司 | A kind of natural cavity protection sleeve pipe |
WO2020153860A1 (en) * | 2019-01-21 | 2020-07-30 | Univerzitet U Beogradu | Minimally invasive catheter |
CN110935091A (en) * | 2019-11-01 | 2020-03-31 | 上海蓓蕊医疗科技有限公司 | Novel catheter, connector and cleaning method thereof |
JP2023506717A (en) * | 2019-12-11 | 2023-02-20 | シー・アール・バード・インコーポレーテッド | Antibacterial coated urethral plugs to reduce catheter-related urinary tract infections |
EP4096759A4 (en) | 2020-01-30 | 2024-03-13 | Rambam Medtech Ltd | Urinary catheter prostheses |
US11896776B2 (en) | 2021-10-19 | 2024-02-13 | Anthony Alcindor | Urinary catheter with integrated coil |
CN115054808A (en) * | 2022-07-05 | 2022-09-16 | 浙江象迈医疗科技有限公司 | Disposable enema multi-balloon anal tube |
Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3527226A (en) * | 1966-02-03 | 1970-09-08 | Cordis Corp | Ventricular catheter with valve and pump flushing means |
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3811450A (en) * | 1971-10-25 | 1974-05-21 | P Lord | Catheters |
US3833003A (en) * | 1972-07-05 | 1974-09-03 | A Taricco | Intravascular occluding catheter |
US3837347A (en) * | 1972-04-20 | 1974-09-24 | Electro Catheter Corp | Inflatable balloon-type pacing probe |
US3938529A (en) * | 1974-07-22 | 1976-02-17 | Gibbons Robert P | Indwelling ureteral catheter |
US3983879A (en) * | 1974-07-25 | 1976-10-05 | Western Acadia, Incorporated | Silicone catheter |
US4228802A (en) * | 1977-06-15 | 1980-10-21 | Medical Products Institute Incorporated | Self-inflating and self-cleaning catheter assembly |
US4240434A (en) * | 1978-10-10 | 1980-12-23 | Newkirk John B | Peritoneo-venous shunt |
US4423725A (en) * | 1982-03-31 | 1984-01-03 | Baran Ostap E | Multiple surgical cuff |
US4465072A (en) * | 1983-02-22 | 1984-08-14 | Taheri Syde A | Needle catheter |
US4738667A (en) * | 1986-11-04 | 1988-04-19 | Galloway Niall T M | Preformed catheter assembly |
US4790810A (en) * | 1985-11-04 | 1988-12-13 | American Medical Systems, Inc. | Ureteral connector stent |
US4932958A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
US4946449A (en) * | 1986-12-18 | 1990-08-07 | Davis Jr Richard C | Indwelling urethral catheter system and method |
US4973301A (en) * | 1989-07-11 | 1990-11-27 | Israel Nissenkorn | Catheter and method of using same |
US5059169A (en) * | 1989-07-07 | 1991-10-22 | C. R. Bard, Inc. | High-friction prostatic stent |
US5078720A (en) * | 1990-05-02 | 1992-01-07 | American Medical Systems, Inc. | Stent placement instrument and method |
US5122154A (en) * | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5135535A (en) * | 1991-06-11 | 1992-08-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5176664A (en) * | 1990-10-09 | 1993-01-05 | Kenneth Weisman | Female voiding assist device and method |
US5282784A (en) * | 1991-10-09 | 1994-02-01 | Mentor Corporation | Injection stent system |
US5445645A (en) * | 1989-02-03 | 1995-08-29 | Debbas; Elie | Apparatus for locating a breast mass |
US5458612A (en) * | 1994-01-06 | 1995-10-17 | Origin Medsystems, Inc. | Prostatic ablation method and apparatus for perineal approach |
US5562622A (en) * | 1995-03-20 | 1996-10-08 | Contimed, Inc. | Self-cleansing bladder drainage device |
US5569219A (en) * | 1994-09-13 | 1996-10-29 | Hakki; A-Hamid | Collapsible catheter |
US5609983A (en) * | 1994-05-25 | 1997-03-11 | Fuji Photo Film Co., Ltd. | Positive working photosensitive compositions |
US5628733A (en) * | 1994-03-03 | 1997-05-13 | Izi Corporation | Surgical drain |
US5716373A (en) * | 1995-07-19 | 1998-02-10 | Datascope Investment Corp. | Support member for reduced diameter balloon catheter, and intra-aortic balloon catheter using the same |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5738654A (en) * | 1995-03-20 | 1998-04-14 | Contimed, Inc. | Self cleansing bladder drainage device |
US5766209A (en) * | 1993-02-19 | 1998-06-16 | Devonec; Marian A. | Prosthesis intended for the treatment of a natural lumen or tract, in particular an endo-urethral prosthesis |
US5785641A (en) * | 1996-05-08 | 1998-07-28 | Urocath Corporation | Male indwelling urethral catheter sizing system and insertion method |
US5865815A (en) * | 1997-04-25 | 1999-02-02 | Contimed, Inc. | Prostatic obstruction relief catheter |
US5876417A (en) * | 1995-07-10 | 1999-03-02 | Devonec; Marian | Detachable catheter apparatus |
US5916195A (en) * | 1998-02-04 | 1999-06-29 | Argomed Ltd. | Internal catheter |
US5964732A (en) * | 1997-02-07 | 1999-10-12 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
US5968069A (en) * | 1996-08-23 | 1999-10-19 | Scimed Life Systems, Inc. | Stent delivery system having stent securement apparatus |
US5971967A (en) * | 1997-08-19 | 1999-10-26 | Abbeymoor Medical, Inc. | Urethral device with anchoring system |
US6004330A (en) * | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US6004290A (en) * | 1996-07-02 | 1999-12-21 | Urocath Corporation | Urethral sizing catheter |
US6119045A (en) * | 1995-05-12 | 2000-09-12 | Prostalund Operations Ab | Device for maintaining a passage for urine through the prostate |
US6167886B1 (en) * | 1997-05-28 | 2001-01-02 | Medi-Globe Vertriebs Gmbh | Device for treatment of male and female urinary incontinence |
US6238383B1 (en) * | 1999-07-20 | 2001-05-29 | Medical Device Solutions | Apparatus and method to facilitate intermittent self-catheterization by a user |
US20020032486A1 (en) * | 2000-06-30 | 2002-03-14 | Argomed Ltd. | Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra |
US6368340B2 (en) * | 1995-04-03 | 2002-04-09 | William W. Malecki | Clamp assembly and method of use |
US20030018358A1 (en) * | 1999-06-25 | 2003-01-23 | Vahid Saadat | Apparatus and methods for treating tissue |
US20030040762A1 (en) * | 2001-08-22 | 2003-02-27 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US6527702B2 (en) * | 2000-02-01 | 2003-03-04 | Abbeymoor Medical, Inc. | Urinary flow control device and method |
US6551304B1 (en) * | 1999-12-01 | 2003-04-22 | Abbeymoor Medical, Inc. | Magnetic retrieval device and method of use |
US20030109837A1 (en) * | 1998-03-13 | 2003-06-12 | Mcbride-Sakal Marcia | Brush to clear occluded stents |
US6719709B2 (en) * | 2000-08-31 | 2004-04-13 | Abbeymoor Medical, Inc. | Diagnostic urethral assembly and method |
US20040078088A1 (en) * | 2002-10-22 | 2004-04-22 | Scimed Life Systems | Male urethral stent device |
US20050267421A1 (en) * | 2004-05-28 | 2005-12-01 | Wing Thomas W | Catheter cleaner |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3894540A (en) * | 1973-10-09 | 1975-07-15 | Bonner F J Jun | Catheter |
US4501580A (en) * | 1980-12-12 | 1985-02-26 | Glassman Jacob A | Indwelling catheters |
US4531933A (en) * | 1982-12-07 | 1985-07-30 | C. R. Bard, Inc. | Helical ureteral stent |
US4813925A (en) * | 1987-04-21 | 1989-03-21 | Medical Engineering Corporation | Spiral ureteral stent |
IL94138A (en) | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
FR2667783A1 (en) | 1990-10-11 | 1992-04-17 | Berberian Jean Pierre | Urinary tract prosthesis |
US5256146A (en) * | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
US5449362A (en) * | 1991-12-19 | 1995-09-12 | Chaisson; Gary A. | Guiding catheter exchange device |
GB9205045D0 (en) * | 1992-03-09 | 1992-04-22 | Amp Holland | High density electrical connector with integral self shunt feature |
US5322501A (en) * | 1992-10-02 | 1994-06-21 | Mahmud Durrani Ayaz | Continent urethral stent for treating and preventing urethral stricture after surgery |
US5300022A (en) * | 1992-11-12 | 1994-04-05 | Martin Klapper | Urinary catheter and bladder irrigation system |
FR2706764B1 (en) * | 1993-06-24 | 1995-08-04 | Synthelabo | |
US5499994A (en) * | 1993-07-30 | 1996-03-19 | American Medical Systems, Inc. | Dilation device for the urethra |
US5466222A (en) * | 1994-03-30 | 1995-11-14 | Scimed Life Systems, Inc. | Longitudinally collapsible and exchangeable catheter |
FR2722413B1 (en) | 1994-07-13 | 1997-02-07 | Marian Devonec | THERAPEUTIC IMPLANT INTENDED FOR THE SELECTIVE CYTOREDUCTIVE TREATMENT OF LIGHT OR NATURAL PATH OBSTRUCTION OF A HUMAN OR ANIMAL BODY |
US5609583A (en) * | 1995-09-21 | 1997-03-11 | Hakki; A-Hamid I. | Collapsible catheter |
FR2773717B1 (en) * | 1998-01-22 | 2000-06-16 | Georges Boussignac | CATHETER FOR BODY CHANNEL |
US6494879B2 (en) * | 1998-10-15 | 2002-12-17 | Scimed Life Systems, Inc. | Treating urinary retention |
US6981987B2 (en) * | 1999-12-22 | 2006-01-03 | Ethicon, Inc. | Removable stent for body lumens |
US7044980B2 (en) * | 2000-02-03 | 2006-05-16 | Boston Scientific Scimed, Inc. | Facilitating drainage |
US6589208B2 (en) * | 2000-06-20 | 2003-07-08 | Applied Medical Resources Corporation | Self-deploying catheter assembly |
AU2001286419A1 (en) | 2000-08-07 | 2002-11-11 | Abbeymoor Medical, Inc. | Endourethral device and method |
WO2002058541A2 (en) * | 2001-01-23 | 2002-08-01 | Abbeymoor Medical, Inc. | Endourethral device & method |
US7422579B2 (en) * | 2001-05-01 | 2008-09-09 | St. Jude Medical Cardiology Divison, Inc. | Emboli protection devices and related methods of use |
US7374560B2 (en) * | 2001-05-01 | 2008-05-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US6685745B2 (en) | 2001-05-15 | 2004-02-03 | Scimed Life Systems, Inc. | Delivering an agent to a patient's body |
US6494855B2 (en) * | 2001-05-16 | 2002-12-17 | Scimed Life Systems, Inc. | Draining bodily fluid |
US7048698B2 (en) * | 2001-06-22 | 2006-05-23 | Abbeymoor Medical, Inc. | Urethral profiling device and methodology |
US7104949B2 (en) * | 2001-08-31 | 2006-09-12 | Ams Research Corporation | Surgical articles for placing an implant about a tubular tissue structure and methods |
CA2462960C (en) * | 2001-10-18 | 2010-10-12 | Abbeymoor Medical, Inc. | Endourethral device & method |
US8328877B2 (en) * | 2002-03-19 | 2012-12-11 | Boston Scientific Scimed, Inc. | Stent retention element and related methods |
US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
WO2005025665A1 (en) | 2003-09-17 | 2005-03-24 | Prostalund Operations Ab | Partial-length, indwelling prostatic catheter with inflation tube anchor and obstruction resistance and clearing |
US7662145B2 (en) * | 2003-09-17 | 2010-02-16 | Prostalund Operations Ab | Partial-length indwelling urinary catheter and method permitting selective urine discharge |
US7766899B2 (en) * | 2003-09-17 | 2010-08-03 | Prostalund Operations Ab | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
IL164563A0 (en) * | 2004-10-13 | 2005-12-18 | Protech Medical Technologies L | Prostate treatment stent |
-
2003
- 2003-09-17 US US10/665,742 patent/US7766899B2/en not_active Expired - Fee Related
-
2004
- 2004-08-18 US US10/921,356 patent/US20050080399A1/en not_active Abandoned
- 2004-09-15 CN CN2004800268804A patent/CN1852747B/en not_active Expired - Fee Related
- 2004-09-15 ES ES04775424T patent/ES2346316T3/en active Active
- 2004-09-15 AT AT04775424T patent/ATE468145T1/en not_active IP Right Cessation
- 2004-09-15 DE DE602004027282T patent/DE602004027282D1/en active Active
-
2010
- 2010-06-18 US US12/818,572 patent/US8518016B2/en active Active
Patent Citations (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3527226A (en) * | 1966-02-03 | 1970-09-08 | Cordis Corp | Ventricular catheter with valve and pump flushing means |
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3811450A (en) * | 1971-10-25 | 1974-05-21 | P Lord | Catheters |
US3837347A (en) * | 1972-04-20 | 1974-09-24 | Electro Catheter Corp | Inflatable balloon-type pacing probe |
US3833003A (en) * | 1972-07-05 | 1974-09-03 | A Taricco | Intravascular occluding catheter |
US3938529A (en) * | 1974-07-22 | 1976-02-17 | Gibbons Robert P | Indwelling ureteral catheter |
US3983879A (en) * | 1974-07-25 | 1976-10-05 | Western Acadia, Incorporated | Silicone catheter |
US4228802A (en) * | 1977-06-15 | 1980-10-21 | Medical Products Institute Incorporated | Self-inflating and self-cleaning catheter assembly |
US4240434A (en) * | 1978-10-10 | 1980-12-23 | Newkirk John B | Peritoneo-venous shunt |
US4423725A (en) * | 1982-03-31 | 1984-01-03 | Baran Ostap E | Multiple surgical cuff |
US4465072A (en) * | 1983-02-22 | 1984-08-14 | Taheri Syde A | Needle catheter |
US4790810A (en) * | 1985-11-04 | 1988-12-13 | American Medical Systems, Inc. | Ureteral connector stent |
US4738667A (en) * | 1986-11-04 | 1988-04-19 | Galloway Niall T M | Preformed catheter assembly |
US4946449A (en) * | 1986-12-18 | 1990-08-07 | Davis Jr Richard C | Indwelling urethral catheter system and method |
US4932958A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
US5445645A (en) * | 1989-02-03 | 1995-08-29 | Debbas; Elie | Apparatus for locating a breast mass |
US5059169A (en) * | 1989-07-07 | 1991-10-22 | C. R. Bard, Inc. | High-friction prostatic stent |
US4973301A (en) * | 1989-07-11 | 1990-11-27 | Israel Nissenkorn | Catheter and method of using same |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US6004330A (en) * | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5078720A (en) * | 1990-05-02 | 1992-01-07 | American Medical Systems, Inc. | Stent placement instrument and method |
US5122154A (en) * | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5176664A (en) * | 1990-10-09 | 1993-01-05 | Kenneth Weisman | Female voiding assist device and method |
US5135535A (en) * | 1991-06-11 | 1992-08-04 | Advanced Cardiovascular Systems, Inc. | Catheter system with catheter and guidewire exchange |
US5282784A (en) * | 1991-10-09 | 1994-02-01 | Mentor Corporation | Injection stent system |
US5766209A (en) * | 1993-02-19 | 1998-06-16 | Devonec; Marian A. | Prosthesis intended for the treatment of a natural lumen or tract, in particular an endo-urethral prosthesis |
US5458612A (en) * | 1994-01-06 | 1995-10-17 | Origin Medsystems, Inc. | Prostatic ablation method and apparatus for perineal approach |
US5628733A (en) * | 1994-03-03 | 1997-05-13 | Izi Corporation | Surgical drain |
US5609983A (en) * | 1994-05-25 | 1997-03-11 | Fuji Photo Film Co., Ltd. | Positive working photosensitive compositions |
US5569219A (en) * | 1994-09-13 | 1996-10-29 | Hakki; A-Hamid | Collapsible catheter |
US5562622A (en) * | 1995-03-20 | 1996-10-08 | Contimed, Inc. | Self-cleansing bladder drainage device |
US5738654A (en) * | 1995-03-20 | 1998-04-14 | Contimed, Inc. | Self cleansing bladder drainage device |
US6368340B2 (en) * | 1995-04-03 | 2002-04-09 | William W. Malecki | Clamp assembly and method of use |
US6119045A (en) * | 1995-05-12 | 2000-09-12 | Prostalund Operations Ab | Device for maintaining a passage for urine through the prostate |
US5876417A (en) * | 1995-07-10 | 1999-03-02 | Devonec; Marian | Detachable catheter apparatus |
US5716373A (en) * | 1995-07-19 | 1998-02-10 | Datascope Investment Corp. | Support member for reduced diameter balloon catheter, and intra-aortic balloon catheter using the same |
US5785641A (en) * | 1996-05-08 | 1998-07-28 | Urocath Corporation | Male indwelling urethral catheter sizing system and insertion method |
US6004290A (en) * | 1996-07-02 | 1999-12-21 | Urocath Corporation | Urethral sizing catheter |
US5968069A (en) * | 1996-08-23 | 1999-10-19 | Scimed Life Systems, Inc. | Stent delivery system having stent securement apparatus |
US6258060B1 (en) * | 1997-02-07 | 2001-07-10 | Abbeymoon Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
US5964732A (en) * | 1997-02-07 | 1999-10-12 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
US5865815A (en) * | 1997-04-25 | 1999-02-02 | Contimed, Inc. | Prostatic obstruction relief catheter |
US6167886B1 (en) * | 1997-05-28 | 2001-01-02 | Medi-Globe Vertriebs Gmbh | Device for treatment of male and female urinary incontinence |
US5971967A (en) * | 1997-08-19 | 1999-10-26 | Abbeymoor Medical, Inc. | Urethral device with anchoring system |
US6221060B1 (en) * | 1997-08-19 | 2001-04-24 | Abbeymoor Medical, Inc. | Urethral device with anchoring system |
US5916195A (en) * | 1998-02-04 | 1999-06-29 | Argomed Ltd. | Internal catheter |
US20030109837A1 (en) * | 1998-03-13 | 2003-06-12 | Mcbride-Sakal Marcia | Brush to clear occluded stents |
US20030018358A1 (en) * | 1999-06-25 | 2003-01-23 | Vahid Saadat | Apparatus and methods for treating tissue |
US6238383B1 (en) * | 1999-07-20 | 2001-05-29 | Medical Device Solutions | Apparatus and method to facilitate intermittent self-catheterization by a user |
US6551304B1 (en) * | 1999-12-01 | 2003-04-22 | Abbeymoor Medical, Inc. | Magnetic retrieval device and method of use |
US6527702B2 (en) * | 2000-02-01 | 2003-03-04 | Abbeymoor Medical, Inc. | Urinary flow control device and method |
US20020032486A1 (en) * | 2000-06-30 | 2002-03-14 | Argomed Ltd. | Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra |
US6719709B2 (en) * | 2000-08-31 | 2004-04-13 | Abbeymoor Medical, Inc. | Diagnostic urethral assembly and method |
US20030040762A1 (en) * | 2001-08-22 | 2003-02-27 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US20040078088A1 (en) * | 2002-10-22 | 2004-04-22 | Scimed Life Systems | Male urethral stent device |
US20050267421A1 (en) * | 2004-05-28 | 2005-12-01 | Wing Thomas W | Catheter cleaner |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060015190A1 (en) * | 2002-04-16 | 2006-01-19 | Robertson David W | Ureteral stent with end-effector and related methods |
US8007540B2 (en) * | 2002-04-16 | 2011-08-30 | Boston Scientific Scimed, Inc. | Ureteral stent with end-effector |
US20050059929A1 (en) * | 2003-09-17 | 2005-03-17 | Magnus Bolmsjo | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
US7766899B2 (en) * | 2003-09-17 | 2010-08-03 | Prostalund Operations Ab | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
US20050288639A1 (en) * | 2004-06-25 | 2005-12-29 | Hibner Michael C | Instrument used in treatment of the urinary incontinence in women |
US20060129136A1 (en) * | 2004-12-09 | 2006-06-15 | Meacham George B K | Catheter |
US9248058B2 (en) | 2005-04-12 | 2016-02-02 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Male external catheter with absorbent and adhesive |
US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
US8328792B2 (en) | 2005-10-27 | 2012-12-11 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US20100016839A1 (en) * | 2006-10-25 | 2010-01-21 | Sobhy Shehata | Apparatus and method for the controlled hydrodistention of the urinary bladder |
US8167870B2 (en) * | 2006-10-25 | 2012-05-01 | Sobhy Shehata | Apparatus and method for the controlled hydrodistention of the urinary bladder |
US20090187143A1 (en) * | 2008-01-18 | 2009-07-23 | Ev3 Inc. | Angled tip catheter |
US8617103B2 (en) | 2008-01-18 | 2013-12-31 | Covidien Lp | Angled tip catheter |
US9504805B2 (en) | 2008-01-18 | 2016-11-29 | Covidien Lp | Angled tip catheter |
US10149961B2 (en) | 2009-07-29 | 2018-12-11 | C. R. Bard, Inc. | Catheter having improved drainage and/or a retractable sleeve and method of using the same |
US9821139B2 (en) | 2009-08-13 | 2017-11-21 | C. R. Bard, Inc. | Catheter having internal hydrating fluid storage and/or catheter package using the same and method of making and/or using the same |
US20110054448A1 (en) * | 2009-08-28 | 2011-03-03 | Navilyst Medical, Inc. | Medical device containing catheter anchoring feature |
US10912917B2 (en) | 2009-12-23 | 2021-02-09 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and method of making and using the same |
US10702671B2 (en) | 2010-03-04 | 2020-07-07 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and a foil outer layer and method of making and using the same |
US10342952B2 (en) | 2010-03-04 | 2019-07-09 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and a foil outer layer and method of making and using the same |
US9731093B2 (en) | 2010-03-04 | 2017-08-15 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and a foil outer layer and method of making and using the same |
US9033149B2 (en) | 2010-03-04 | 2015-05-19 | C. R. Bard, Inc. | Catheter assembly/package utilizing a hydrating/hydrogel sleeve and a foil outer layer and method of making and using the same |
US9339633B2 (en) * | 2010-06-11 | 2016-05-17 | Universitatsmedizin Der Johannes Gutenberg Universitat Mainz | Balloon catheter system for draining fluids from hollow organs, body cavities or cysts and/or for supplying medication |
US20130123622A1 (en) * | 2010-06-11 | 2013-05-16 | Universitätsmedizin Der Johannes Gutenberg Universität Mainz | Balloon catheter system for draining fluids from hollow organs, body cavities or cysts and/or for supplying medication |
US20120158025A1 (en) * | 2010-12-15 | 2012-06-21 | Christopher Anderson | Anastomosis device and related methods |
US11607524B2 (en) | 2011-03-14 | 2023-03-21 | Rochester Medical Corporation | Catheter grip and method |
US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US10569051B2 (en) | 2011-03-14 | 2020-02-25 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US20150088090A1 (en) * | 2012-02-21 | 2015-03-26 | Hospi Corporation | Method and apparatus for a clog resistant orifice |
US10780244B2 (en) | 2012-11-20 | 2020-09-22 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter in a bag without additional packaging |
US11730919B2 (en) | 2012-11-20 | 2023-08-22 | Rochester Medical Corporation | Catheter in bag without additional packaging |
US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
WO2014116718A1 (en) * | 2013-01-22 | 2014-07-31 | Percutaneous Systems, Inc. | Ureteral stent and method and system for its deployment |
US9694113B2 (en) | 2013-03-13 | 2017-07-04 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US8998882B2 (en) | 2013-03-13 | 2015-04-07 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US10518000B2 (en) | 2013-03-13 | 2019-12-31 | C. R. Bard, Inc. | Enhanced pre-wetted intermittent catheter with lubricious coating |
US10857324B2 (en) | 2014-08-26 | 2020-12-08 | C. R. Bard, Inc. | Urinary catheter |
US10874825B2 (en) | 2014-08-26 | 2020-12-29 | C. R. Bard, Inc. | Urinary catheter |
US11850370B2 (en) | 2014-08-26 | 2023-12-26 | C. R. Bard, Inc. | Urinary catheter |
US10518069B2 (en) | 2016-10-28 | 2019-12-31 | Integra LifeSciences Switzerland Sarl | Implantable valve assembly with extended lifespan |
US11547599B2 (en) | 2017-09-19 | 2023-01-10 | C. R. Bard, Inc. | Urinary catheter bridging device, systems and methods thereof |
US20230010429A1 (en) * | 2019-09-06 | 2023-01-12 | Blue Halo BioMedical, LLC | Coil catheter, method of use, and method of manufacture |
KR20220080068A (en) * | 2020-03-05 | 2022-06-14 | 울산대학교 산학협력단 | Foley catheter assembly |
KR102484716B1 (en) * | 2020-03-05 | 2023-01-03 | 울산대학교 산학협력단 | Foley catheter assembly |
Also Published As
Publication number | Publication date |
---|---|
ES2346316T3 (en) | 2010-10-14 |
DE602004027282D1 (en) | 2010-07-01 |
US8518016B2 (en) | 2013-08-27 |
ATE468145T1 (en) | 2010-06-15 |
CN1852747B (en) | 2010-09-08 |
US20050059929A1 (en) | 2005-03-17 |
US7766899B2 (en) | 2010-08-03 |
CN1852747A (en) | 2006-10-25 |
US20100256608A1 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050080399A1 (en) | Urinary catheter and method with increased resistance to obstructions | |
EP1680174B1 (en) | Partial-length, indwelling prostatic catheter with coiled inflation tube | |
US8475435B2 (en) | Partial-length indwelling urinary catheter permitting selective urine discharge | |
EP0813434B1 (en) | Slowly dilating device for the urethra | |
US7264609B2 (en) | Indwelling urinary catheter | |
US6949125B2 (en) | Ureteral stent with end-effector and related methods | |
EP1434536B1 (en) | Prostatic stent and delivery system | |
JP3245156B2 (en) | Apparatus for the treatment of compressed tubes | |
US6893430B2 (en) | Urethral catheter and guide | |
EP0935977A2 (en) | Urethral catheter and guide | |
JP2004513679A (en) | Prostate stent with local tissue engaging means and method for preventing occlusion of the prostatic urethra | |
MXPA97006720A (en) | Device to slowly dilate the ure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PROSTALUND OPERATIONS AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOLMSJO, MAGNUS;SCHELIN, SONNY;REEL/FRAME:016078/0477 Effective date: 20041027 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |